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Abstract 
The formation and maintenance of physical and functional barriers allows organisms to 
compartmentalize tissues, restrict the movement of cells, ions and small solutes as well as 
allows for terrestrial living. The main aim of this thesis was to examine if cell autonomous 
insulin/IGF-1 signaling regulates barrier formation/function in mammals, specifically the 
epidermal skin barrier as well as the vascular barrier. Mammalian epidermis is a multilayered 
stratified epithelium serving as a protective barrier against external insults and dehydration. 
Two compartments contribute to epidermal barrier function: (i) the outermost stratum 
corneum consisting of corneocytes embedded in a crosslinked matrix of mostly lipids and (ii) 
intercellular tight junctions present in the uppermost viable Stratum granulosum. Vascular 
barrier property on the other hand is largely dependent on functional intercellular junctions 
such as tight and adherens junctions that seal of the paracellular space between endothelial 
cells. 
Using Cre-loxP technology, the cell autonomous role of insulin receptors (IR)/IGF-1 receptors 
(IGF-1R) in the formation of epidermal barrier and maintenance of vascular barrier were analysed 
in mice with epidermal- and adult vascular endothelial-specific inactivation of both receptors 
(dkoepi-/- and dkoveinduc-/-). Dkoepi-/- mice showed transepidermal water loss and lethality within two 
days after birth, implying compromised epidermal barrier formation. Analysis of outside-in 
barrier formation using dye exclusion assays showed a strongly delayed acquisition of embryonic 
epidermal barrier in dkoepi-/- mice compared to control mice, suggesting impaired formation of the 
stratum corneum. This was accompanied by altered corneocyte morphology and a reduction in the 
level of free ceramides in combination with an accumulation of precursor ceramides (GlcCers) in 
the stratum corneum of dkoepi-/- mice as well as a small reduction in monomeric filaggrin. 
Analysis of the insight-out barrier did not reveal any consistent differences yet, despite small 
differences in tight junctional protein expression. Thus, epidermal Insulin/IGF-1 signaling is 
essential for epidermal barrier formation by regulation proper formation of the stratum corneum. 
Temporal inactivation of IR and IGF-1R in adult vascular endothelial cells did not result in any 
obvious morphological alterations in the vasculature in a range of tissues. Injection of tracer 
molecules with different molecular size followed by whole mount analysis of the retina or skin 
sections did not reveal any obvious vascular leakage or abnormal vascular patterning. Thus, 
vascular endothelial IR/IGF-1R signaling does not seem to regulate vascular integrity under 
steady state conditions. An important caveat in these experiments was the observation that the 
inactivation of the IGF-1R was variable and that loss of over 90% of IGF-1R is insufficient to 
disturb vascular integrity.  
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Zusammenfassung 
Die Ausbildung und Aufrechterhaltung von physikalischen und funktionellen Barrieren erlaubt 
Organismen Gewebe in Kompartimente zu unterteilen, die Bewegungsfähigkeit von Zellen, Ionen und 
kleine gelöste Substanzen einzuschränken und sichert so die Überlebensfähigkeit im terrestrischen 
Leben. Das Hauptziel dieser Arbeit war herauszufinden, ob Zell autonome Insulin/IGF- Signalisierung 
Barriereausbildung und Funktion in Säugetieren, insbesondere die epidermale Hautbarriere und 
vaskuläre Barriere, reguliert. 
Die Epidermis von Säugetieren repräsentiert ein geschichtetes Epithel, welches als schützende 
Barriere gegen äußere Einflüsse und Dehydrierung wirkt. Zwei Kompartimente tragen zur 
epidermalen Barrierefunktion bei: (i) das äußerste stratum corneum besteht aus Korneozyten, welche 
in eine vernetzte Matrix aus Lipiden eingebettet sind und (ii) intrazelluläre Verschlusskontakte (zonula 
occludens, tight junction), welche sich in dem obersten Stratum granulosum befinden. Vaskuläre 
Barriereeigenschaften sind größtenteils abhängig von funktionellen intrazellulären Kontaktstellen wie 
tight  und adheres junctions, welche den parazellulären Raum zweichen Endothelzellen versiegeln. 
Durch Nutzung der Cre-loxP Technology wurde die Rolle des Insulinrezeptors (IR) sowie des IGF-1 
Rezeptors (IGF-1R) in der Ausbildung der epidermalen Barriere und Aufrechterhaltung von 
vaskulären Barrieren in Mäusen mittels epidermal-spezifischer sowie vaskulärer endothelial-
spezifischer Inaktivierung von beiden Rezeptoren (dkoepi-/- und dkoveinduc-/-) analysiert. Dkoepi-/- Mäuse 
wiesen einen transepidermalen Wasserverlust auf und starben zwei Tage nach der Geburt, was auf eine 
beeinträchtigte epidermale Barrierefunktion hindeutet. 
Analyse von Einwärtsbarriereausbildung durch Gebrauch von Farbstoff-Penetrations Versuchen 
wiesen  eine verspätete Ausbildung der epidermalen Barriere in dkoepi-/- im Vergleich zu 
Kontrollmäusen auf, welches auf eine beeinträchtigte Formation des stratum corneums  hindeutet. 
Diese Beobachtung wurde unterstützt durch veränderte Korneozyten Morphologie und einer 
Reduktion bezüglich des Gehalts von freien Ceramiden in Kombination mit einer Akkumulierung von 
Vorläufer Cermaiden (GlcCers) im Stratum Corneum von dkoepi-/- Mäusen sowie einer Reduktion 
monomerischen Filaggrins. Analyse der Auswärtsbarriere zeigten keine konsistenten Unterschiede 
zwischen Kontroll Mäusen und Mutanten, bis auf geringe Unterschiede bezüglich der Expression des 
tight juncion Strukturproteins Claudin 1. Insgesamt wurde gezeigt, dass epidermale Insulin/ IGF-1 
Signalisierung essentiell für die Ausbildung der epidermalen Barriere durch die Regulation der 
Bildung des Stratum Corneums ist. 
Temporelle Inaktivierung des IR und IGF-1R in adulten vaskulären Endothelzellen resultierte in 
keiner offensichtlichen morphologischen Veränderung in den Blutgefäßen im Bereich von Geweben. 
Injektion von Tracer Molekülen von unterschiedlicher Molekulargröße gefolgt von Retina Analysen 
konnten keine vaskuläre Durchlässigkeit oder abnormale vaskuläre Ordnung bestätigen. 
Folglich scheint vaskulär endotheliales IR/ IGF-1R Signalisierung keine Rolle in der Regulierung der 
vaskulären Intaktheit unter Gleichgewichtsbedingungen zu besitzen.  
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   1 Introduction 
1.1 In vivo barriers and their functional importance 
In multicellular organisms, certain tissues must be separated from each other and protected 
against the outside environment. Continuous epithelial and endothelial sheets accomplish this by 
providing cellular borders that cover the external and internal surfaces of the body. 
Ultrastructural visualization reveals the complexes between adjoining cells in these sheets as 
gap junctions, desmosomes, adherence junctions (AJs) and tight junctions (TJs). These 
intercellular complexes act in concert to selectively control the influx and efflux of molecules 
and particles through their protective shield. The epidermis which separates the body from the 
outside milieu acts as a barrier constructed via piled up stacks of differentiated keratinocytes. 
The intercellular junctional complexes between the flattened keratinocytes and the components 
of the cornified layer of the epidermis shape the barrier function of skin. Therefore, skin is a 
semipermeable epithelium with multiple functions including, protection against entry of 
infectious or toxic substances, barrier against dangerous solar UV irradiation and most 
importantly it prevents the escape of body moisture and heat (Reviewed by Candi et al., 2005).  
The vascular barrier function on the other hand depends on a single sheet of endothelial cells 
lined next to each other and joint together by specific intercellular adhesion complexes (Fig.1). 
The vascular barrier is almost a one way barrier which controls the efflux of solutes and 
molecules out of the blood into underlying tissues (Turksen and Troy, 2004). 
1.2 Endothelial barriers 
1.2.1 Adherens junctions, tight junctions and desmosomes 
An essential property of vascular endothelial cells is their assembly into a physical and ion- and 
size-selective barrier. According to ultrastructural observations it has been shown that 
endothelial cells have specialized junctional regions that are comparable to AJs/TJs in epithelial 
cells; however, whereas in most epithelia TJs are concentrated at the more apical side of the 
intercellular cleft, in the endothelium TJs are frequently intermingled with AJs all the way along 
the cleft. Furthermore, in contrast to epithelial cells, endothelial cells lack desmosomes (Fig.1) 
(Reviewed by Dejana, 2004). 
Another difference of the vascular barrier system compared to epithelial barriers is the presence 
of vascular fenestrations in different tissues such as skin and choroids which provides a 
differential permeability preference based on the size parameter of the diffused molecules 
(Takada and Hattori 1972, Maxwell and Pease, 1956). In contrast to fenestrated endothelial cells 
in the choroid and skin vasculature, the TJs in the blood brain barrier tightly regulate the 
transpass of ions and molecules to the extravascular brain tissue (Nitta et al., 2003). 
1.2.2 Retina and Blood-Retinal-Barrier  
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Retina is a transparent neural tissue positioned between the vitreous body and the retinal 
pigmented epithelium and consists of multiple layers; the nerve fiber layer, ganglion cell layer, 
inner plexiform layer, inner nuclear layer, outer plexiform layer, outer nuclear layer, and the 
outer segments of rods and cones. Central retinal artery and the choroidal blood vessels provide  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
85% and 15% of retinal blood supply. In the human retina, four main branches arise from the 
central retinal artery to supply three capillary plexuses: the radial peripapillary in nerve fibre 
layer, the inner capillary in ganglion cell layer, and the outer capillary networks in junction of 
inner nuclear and outer plexiform layers. The mouse counterparts of retinal vessels are primary 
plexus, inner or superficial and outer deeper plexus (Fig.2A) (Reviewed by Erickson et al., 
2007).   TJs in retinal pigment epithelium (RPE) and the blood vessels of the retina form the 
outer and inner barriers of the blood-retinal-barrier (BRB) respectively. The BRB is similar to 
the blood brain barrier in that it serves as a size and charge selective barrier that regulates the 
local environment of the neural retina. As with TJs elsewhere, RPE cells express tight junctional 
proteins, occludin-1, cldns, and ZO-1 (Williams and Rizzolo, 1997; Tserentsoodol et al., 1998) 
and control the flow of solutes and fluid from the surrounding fenestrated capillaries of the 
choriocapillaris into the outer retina (outer retinal barrier) and the retinal vessels directly restrict 
diffusion from the vessel lumen into the retinal parenchyma (inner retinal barrier) (Fig.2B) 
(Shakib and Cunha-Vaz, 1966).  
Although permeability of BBB or BRB is controlled by the biochemical and biophysical 
properties of microvascular endothelial cells, the vascular barrier function in CNS is generally 
the outcome of interactions of endothelial cells with the basement membrane and bordering glial 
Figure 1: The organization of TJs in simple epithelium, stratified epithelia and endothelial cells. (A) 
Tissues with simple epithelia have TJs in the most apical pole of the cells. (B)TJs in the stratified epithelium 
of the skin are positioned in the mid-granular layer of the skin. (C) Endothelial TJs are located apically but 
they tend to be intermingled with AJs.  
A 
C 
B 
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cells, such as microglia and astrocytes, which together with neurons and perivascular pericytes 
constitute the neurovascular unit (NVU) (Fig.2C) which is an essential assembly in the vascular 
barrier function of CNS. Among other cell types in NVU, pericytes are believed to closely 
contribute to the integrity of neural vascular barrier as they share the same basement membrane 
with the endothelial cells and cover 22 to 32% of the capillary surface. Pericyte positioning on 
the microvessel and the coverage amount varies between different microvessel types which 
seems to correlate with the degree of tightness of the endothelial junctions (Reviewed by 
Cardoso et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   1.3 Epidermal skin barrier  
Figure 2: (A) H&E showing different cell types in retinal section. (B) Scheme showing the neural 
and vascular network in normal retinal cross section. Arrowhead: radial peripapillary and 
underlying inner capillary networks, arrow: outer capillary network. These networks build the inner 
BRB. Open arrow: The choroids supply nutrients to the outer retina. Diffusion into the retina is 
controlled by the retinal pigmented epithelium (RPE). RPE layer forms the outer BRB (C) Scheme of 
neurovascular unit assembly. Endothelial cells are covered by a basement membrane (shown in blue) 
and surrounded by different cell types; pericytes, astrocytic endfoot, neurons and microglial. Part B and 
part C are adapted from Erickson et al., 2007 and Cardoso et al., 2010 respectively. 
A 
C 
B 
Radial peripapillary and 
inner capillary networks 
Outer capillary 
network  
Choroids  
RPE layer 
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1.3.1 Adherens junctions, tight junctions and desmosomes 
The competency of epidermal barrier depends at least on proper function of three major 
components: the cornified envelope and lipid lamellar sheets in the cornified layer and 
intercellular AJ/TJ complexes in the upper granular layer. Based on dye penetration assays on 
mouse skin using lucifer yellow and toluidine blue, cornified layer forms the outside-in barrier 
(Hardman et al., 1998; Jennemann et al., 2007; Epp et al., 2007). The AJ formation in the 
epidermis leads to proper TJ assembly in the epidermis and TJs are engaged in the formation of 
inside-out barrier, as TJs in granular layer restrict the diffusion of subcutaneously injected biotin 
to the cornified layer (Furuse et al., 2002; Tunggal et al., 2005). In the epidermis 
hemidesmosomes are restricted to the basal layer, whereas desmosomes are found in all layers 
of the epidermis (Getsios et al., 2004). 
1.3.2 Stratum corneum 
Cornified envelope replaces the plasma membrane of cells in the cornified layer and comprises 
a series of crosslinked protein components which ultimately result in the formation of a highly 
resilient corneocytes. The corneocytes are therefore very resistant to boiling in solutions 
containing detergent and reducing reagents. Interconnected corneocytes by corneodesmosomal 
components and intercorneocyte lipid stcks together form the stratum corneum (Rice et al., 
2003). 
1.3.3 Acquisition of outside-in epidermal barrier in mouse 
Analysis of embryonic mouse skin using dye penetration assay with toluidine blue has 
determined that the development of such a barrier happens late in gestational period. Indeed 
Harman et al., (1998) identified the start points of barrier acquisition as sites which blocked dye 
penetration in late embryonic E16 skin at distinct initiation sites. The barrier acquisition in 
mouse follows a highly patterned order during development with the emergence of initial 
barrier-competent start sites in the back skin and then on cranial site and nostrils which 
gradually spreads in the form of moving fronts to the front skin over 1-2 days of development 
depending on the mouse strain.  
Skin barrier development happens concurrently with the component deposition, maturation and 
thickening of the cornified layer. Mature (26 kDa) FLG would not account for barrier 
acquisition as despite the presence of the profilaggrin and 2X-FLG intermediates, monomeric 
FLG was detected only in post-barrier (17 day) epidermis. Since loricrin as one of the last 
components to be incorporated into the cornified envelope, has constant expression during the 
last stages of barrier acquisition and due to its overlapping redistribution to the cornified cell 
membranes during barrier development, it is possible that cornified envelope maturation 
correlates with acquisition of barrier function (Harman et al., 1998).  
1.4 Molecular components of barriers  
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1.4.1 TJs, AJs and desmosomes  
In simple epithelia which consist of a single layer of polarized cells, TJs are the most apical 
structure of the apical complex demarcating the border between apical and basolateral 
membrane domains. However in stratifying epithelia of the mammalian epidermis functional 
TJs occur only in the upper viable part of the granular layer. The intercellular membrane space 
of TJs is almost completely obliterated, hence their alternative name zonulae occludens. AJs are 
positioned immediately below TJs and characterized by two apposing membranes, which are 
separated by ~20 nM, that run parallel over a distance of 0.2-0.5 mm (Reviewd by Niessen, 
2007, Michels et al., 2009a).  
A combination of transmembrane and cytoplasmic proteins constitutes both the AJs, TJs and 
desmosomes. These components can be categorized into three general categories: (i) structural 
proteins necessary for initiation of the junctions, (ii) plaque proteins associated with the 
cytoskeleton, and (iii) signaling/polarity proteins. The nectin-afadin and cadherin-catenin 
complexes are building components of AJs where nectin and cadherin are transmembrane 
proteins and afadin and catenin are cytoplasmic proteins, the latter two proteins can interact 
with actin cytoskeleton thereby linking the AJs to cytoskeleton (reviewed by Niessen, 2007). 
Desmosomes are formed by adhesion receptors belonging to the cadherin super family i.e. 
desmogleins and desmocollins. Desmosomes link intermediate filament cytoskeleton to the 
plasma membrane (Nathke et al., 1994).  
Single-pass membrane proteins such as junctional adhesion molecules (JAM), and four-pass 
transmembrane domains such as cldns and occludin together with cytoplasmic proteins of ZO 
family and cingulin are involved in the connection of TJs to the actin cytoskeleton. These 
scaffolding proteins recruit several signaling proteins and transcription factors to the TJ sites 
(Fig.3). More than 40 proteins, including transmembrane, scaffolding and signaling proteins, 
have been found to be associated with TJs and form multimeric protein complexes to receive 
and send regulatory signals (González-Mariscal et al., 2003).  
1.4.1.1Claudin proteins 
Cldns are Transmembrane proteins, with MW of 20–27 kDa that appear to constitute the 
ultrastructural TJ strands. Transfection of cldn-1 and -2 into cultured fibroblasts resulted in the 
formation of a network of typical tight junctional strands as evidenced by freeze-fracture analysis 
(Furuse et al., 1998b). Subsequent research has expanded the member number of this multigene 
family in mouse and human to 24 genes. Differential expression has been described for cldns, 
suggesting their tissue specific function. For instance cldn-1 deficient mice die rapidly due to 
accelerated epidermal water loss and show poorly  developed TJs in their epidermis, indicating  
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that cldn-1 is the crucial barrier type cldn in the epidermis and is required for the maintenance 
of the inside-out barrier in mammalian epidermis. In addition to cldn-1 other cldn proteins 
including cldns-4 -5 -6 -7 -11 and -12 are also found to be expressed in the epidermis, although 
the role of each cldn in the maintenance of epidermal barrier property is not clear (Furuse et al., 
2002). 
On the other hand, cldn-1 and -5 are associated with maintenance of normal BBB function 
(Vorbrodt and Dobrogowska, 2003) and appear to be important in angiogenesis and in disease 
processes with disturbed vascular permeability. Indeed cldn-5 knockout mice are characterized 
by a size-selective loosening of TJs in BBB against small molecules (<800 Daltons) but not 
larger molecules showing that cldn-5 regulates size selectivity of the BBB (Nitta et al., 2003). 
1.4.1.2 Occludin 
Occludin as the first TJ transmembrane molecule discovered is a protein with MW of 
approximately 65 kDa (Furuse et al., 1993). Occludin deficiency in mice did not exhibit an 
evident alteration in epidermal barrier function although the vascular barrier function in these 
mice was not determined, nevertheless, the mice exhibited several different phenotypes, such as 
growth retardation, male sterility, gastritis and mineral deposits in the brain, suggesting vascular 
barrier impairment in CNS (Saitou et al., 2000). Occludin shows a highly consistent expression 
in cerebral endothelium and reveals staining in distinct continuous pattern along the cell 
margins in CNS endothelium, while it is almost sparsely distributed in non-neural endothelium 
Figure3: Schematic representation of the basic structural transmembrane and cytoplasmic 
components of tight junctions. Cldns and occludin are 4-pass proteins while JAM-1 is single-
pass. Each cytoplasmic protein, ZO-1 or ZO-2 is important for clustering of cldns and occludin, 
resulting in the formation of tight junctional strands. The role of the other scaffolding proteins (ZO-
3/MAGI/MUP1) is less clear. The ZOs and cingulin can provide a direct link to the actin 
cytoskeleton (adapted from Niessen, 2007). 
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(Hawkins and Davis, 2005). Tricellulin is another TJ protein identified with structural similarity 
to occludin. Unlike other TJ proteins, tricellulin is enriched only at tricellular TJs, where it 
enforces the barrier function of epithelial cell sheets (Ikenouchi et al., 2005). 
1.4.1.3 Junctional adhesion molecules (JAMs). 
The 40-kDa, IgG-like JAM family proteins are the third group of transmembrane receptors 
found at tight junctions. The JAM family comprises JAM-1, JAM-2, and JAM-3, also 
designated as JAM-A, JAM-B and JAM-C, respectively. In the form of single-pass proteins, 
JAMs have a large extracellular domain that mediates homophilic and probably also 
heterophilic interactions in the tight junctional region but do not induce the formation of TJ 
strands when expressed in fibroblasts. Cell type specificity seems to govern cellular tendency in 
expressing different JAM members.  For example, JAM-1 is predominantly expressed in 
epithelial cells while epithelia do not express other related JAMs (-2 and -3) and lymphatic cells 
express only JAM-1 and -2. On the other hand all JAM family proteins (-1, -2 and -3) are 
present in various endothelial cells, where they appear to differentially regulate paracellular 
permeability. Brain endothelial cells express only JAM-1 but not JAM-2 which together with 
JAM-1 expression in epithelia implies a putative function in TJ formation or function (Aurrand-
Lions et al., 2001).  
However, expression of JAMs is not exclusively restricted to cells with TJs but also other cells 
such as circulating monocytes, neutrophils, lymphocytes, and platelets, as well as dendritic cells 
also express JAMs thereby contributing to their transendothelial migration (reviewed by Ebnet 
et al., 2004) 
1.4.1.4 Zonula occludens (ZO) proteins  
Scaffolding zonula occludens or ZO proteins are cytoplasmic phosphoproteins that associate 
with the cytoplasmic side of TJs and provide a link between TJs and the actin cytoskeleton. 
Importantly as so far no direct interactions have been identified between occludins, cldns and 
JAMs, cytoplasmic binding partners must fulfil this scaffolding function. ZO proteins (ZO-1, 
ZO-2, and ZO-3) belong to the membrane-associated guanylate kinase-like homologs family 
and are characterized by three N-terminal PDZ domains, an SH3 domain followed by the GUK 
domain. The multiple binding domains in ZO-1 have scaffolding function, with the PDZ-1 
region binding to the cldn, the PDZ-2 domain binding to ZO-2, and the SH3-GuK region 
binding to both the occludin and the adherens junction proteins afadin and cadherin via α-
catenin. The C-terminus of ZO molecules can associate with actin which provides a direct link 
with the cytoskeleton (reviewed by Niessen, 2007). ZO-1, a phosphoprotein with MW 220-kDa 
and broad expression in most endothelial and epithelial cells is localized to tight junctions via its 
actin-binding domain and despite its expression in cell types without TJ formation, no TJ exists 
without ZO-1 therefore immunostaining for ZO-1 reflects maturation status of TJs. In addition, 
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ZO-1can also directly interact with JAMs and form homodimers or heterodimers with either 
ZO-2 or ZO-3. Very much like ZO-1, ZO-2 associates with transmembranous proteins of the TJ 
and transcription factors, and it is localized in the nucleus during stress and proliferation. It is 
not only considered as an extremely important structural protein, but also a nuclear factor 
affecting gene expression and blocking cell cycle progression (Niessen, 2007).  
1.4.1.5 Cadherin/catenin adhesion complex 
Classical cadherins were the first family of adhesion molecules found in the adherens junction 
and include type I, single-pass transmembrane glycoproteins that mediate Ca2+-dependent 
intercellular adhesion. Specific adhesion function is conferred by the cadherin ectodomain, 
which engages an identical molecule on the surface of an opposing cell, thereby called 
“homophilic” interaction; whereas the cadherin cytoplasmic domain mediates key structural and 
signaling activities required for adhesion through its association with three distinct cytoplasmic 
proteins known as catenins. β-catenin (or the highly homologous γ-catenin/plakoglobin) are 
arm-repeat proteins (Michels et al., 2009a-b). 
Calcium is key factor to allow homophilic interaction between E-cadherin molecules and crystal 
structures of ectodomain regions containing multiple EC domains show that the connections 
between successive domains are rigidified by Ca2+ coordination (Reviewed by Shapiro and 
Weis, 2009). In cultured keratinocytes, increased extracellular calcium levels stimulate 
formation of adherens junctions, causing both cytoskeletal reorganization and complexing of 
junctional proteins such as E-cadherin and α-catenin. Actin polymerization and formation of 
filopodia are among the earliest responses to raised extracellular Ca2+ leading to keratinocytes 
differentiation (Vasioukhin et al., 2000). 
Three major cytoplasmic partners of E-cadherin are α-catenin, β-catenin, and plakoglobin (also 
known as γ-catenin). The cytoplasmic region of E-, N-, and P-cadherins bind to β-catenin or 
plakoglobin, which in turn binds to α-catenin. The high level of sequence identity in the 
cadherin cytoplasmic region suggests that all classical cadherins interact with the catenins in 
this fashion. α-Catenin has a number of binding partners, including actin. In addition, p120 
catenin, which belongs to a subfamily of armadillo proteins, interacts with juxtamembrane 
fragment of the cadherin cytoplasmic domain (Reviewed by Shapiro and Weis, 2009; Niessen 
and Gottardi, 2008). 
1.4.2 Regulation of TJs/AJs by the polarity complex aPKC/Par3/Par6 
Several proteins regulating epithelial cell polarity have been characterized at TJs and AJs. One 
such complex is ternary aPKC/Par3/Par6 complex which was initially identified in a genetic 
screen searching for mutations that disrupted polarization of the Caenorhabditis elegans zygote 
(Tanentzapf and Tepass, 2003). Functional interference with any of these proteins affects 
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paracellular permeability, indicating their importance in the assembly of functional TJs 
(Anderson et al., 2004; Shin et al., 2006; Chen and Macara, 2005).  
      The Par complex is potentially capable of regulating AJ formation in endothelial cells. This 
relies on direct interaction of Par-3 and Par-6 with VE-cadherin. Among other types of cadherin 
molecules, this binding in only possible for VE-cadherin as P- N- and E-cadherin lack the PDZ 
domain required for interaction with Par proteins. This association might account for the distinct 
type of cell polarity pattern which is seen in endothelial cells. This interaction is suggestive of a 
uniquely localized aPKC-free Par-3, Par-6 protein complex at AJs via direct binding of both Par 
proteins with VE-cadherin which does not appear to cause polarization (Iden et al., 2006).  
1.4.2.1 Genomic structure and protein isoforms of mouse Par-3 
According to the available online genomic data, the mammalian homologue of C. elegans Par-3 
gene, ASIP (atypical PKC isotype-specific interacting protein) which was initially characterized 
by Izumi and colleagues (1998), is mapped to the distal end of the mouse chromosome 8 in 
chromatid region E2. The full-length mouse Par-3 transcript comprises 25 known coding exons 
(Fig.4A) and yields a 180 kDa protein of 1337 amino acids which consists of three domains, 
CR1 in the NH2-terminal domain, CR2 in the middle and a CR3 domain in the COOH-terminal 
(variant3, Pubmed ID, NM_033620.1). There are also other splice variants present in mouse 
tissues and cells which have the molecular weight of 150 and 100 kDa and result from 
termination of transcription in exons 19 and putative 15b of the full length gene respectively. 
The 180 kDa isoform appears to be the most abundant variant during embryonic development 
and in mouse brain whereas in heart and kidney the usual isoform is the 150 kDa variant 
(Fig.4B) (Izumi, et al., 1998; Lin et al., 2000). However Duncan and colleagues (2005) have 
reported the presence of additional transcripts for Par-3 in mouse oocyte and fertilized eggs 
which had not been characterized earlier and are supposedly originated via utilizing an 
alternative start codon which maps to exon 4 of the full length gene. The novel isoforms consist 
of 13 and 21 exons resulting in proteins with corresponding molecular weights of 73/76 kDa, 
(variant 2, Pubmed ID NM_001013580.2) and 133/135 kDa (variant1, Pubmed ID, 
NM_001013581.2) respectively. (Duncan et al., 2005).  
   1.4.2.2 Protein domains and interaction partners of mouse Par-3 
       Par-3 CR1 domain in the N-terminal region, is an oligomerization domain required for Par3 
self-oligomerization as in yeast two-hybrid system the full length Drosophila homolog of the 
Par3, Bazooka, was able to bind to the mammalian CR1 domain. This interaction is direct and 
has been further validated using in vitro translation system (Benton and St.Johnston, 2003). The 
CR2 domain comprises 3 PDZ domains, PDZ-1, PDZ-2 and PZD-3. The PDZ1 domain is 
interacting partner for another polarity protein, Par-6 (Johansson et al., 2000; Ebnet et a.l, 2001) 
as well as for integral Ig-like cell-cell adhesion molecules, JAM-1, -2 and -3, nectin-1 and 
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nectin-3 (Ebnet et al., 2003; Takekuni et al., 2003). Par3 is expressed by endothelial cells in 
most tissues such as the tongue and the heart endothelium where its association with JAMs is 
proposed to anchor the PAR-3/aPKC/PAR-6 complex to TJs (Ebnet et al., 2003). Besides 
mediating role in cell polarity and TJ formation, it is shown recently that the N-terminal 
dimerization and PDZ1 domains of Par-3 bind to dynein light intermediate chain 2 that results 
in the proper centrosome orientation during cell migration via local regulation of MT dynamic 
(Schmoranzer et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      The PDZ2 domain of Par-3 shows high affinity to phosphoinositides (PIPs) and this binding is 
critical for the its localization to cell membrane in MDCK cells, interestingly the same study 
revealed direct binding of the PIP Phosphatase, PTEN, to the juxtaposing PDZ3 domain of 
Par-3 which could facilitate quick hydrolysis of PIP3 by nearby PTEN (Wu et al., 2007). 
Later it was demonstrated that localization of the PTEN to cell-cell junctions is essential for 
the polarization of mammalian epithelial cells in vitro. As polarized distribution of PIP-2 and 
PIP-3 lipids is important determinant of cell polarity, Par-3 appears to function as a gate 
Figure 4: (A) Genomic structure of PAR-3. Exons, represented as boxes, are numbered and drawn to 
scale. White fraction of box in exons 1 and 25 shows 5´and 3´UTR regions. (B) Diagrams of different 
possible Par-3 proteins isoforms. All possible protein isoforms are drawn under their respective coding 
exon in the genome. Two Par-3 start codons and three stop codons exist. The first start codon is situated in 
exon 1 and second one in exon 4. In total six isoforms are possible. The N-terminal region with CR-1 
domain, three PDZ domains and the aPKC binding site is shown. The PDZ domains but not CR-1 and aPKC 
domains are present in all isoforms. 
A 
B 
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keeper to maintain the phosphoinositide concentration gradient in polarized cells and therefore 
guide the polarity cues (Feng et al., 2008).  
The CR3 domain contains aPKC binding site, inside which there is a region with two highly 
conserved serine residues (827 and 829). Par-3/aPKC association leads to Par-3 Ser827 
phosphorylation by aPKC resulting in its detachment from aPKC that is observed during the 
initial phase of tight junction formation and is believed to be a critical step in epithelial 
polarization in mammalian cells (Izumi et al., 1998; Hirose et al., 2002; . Nagai-Tamai et al., 
2002). The carboxy-terminal region of Par-3 contains a direct binding site for the Rac 
exchange factor Tiam1. Par-3 binding with Tiam-1 is speculated to either inhibit Tiam1 
activity or sequester Tiam1 to a region of the cell where it is not accessible to Rac. 
Nevertheless, this binding is essential for tight junction assembly in simple epithelial cells via 
inhibition of Rac by Tiam1 in TJ sites (chen and Macara, 2005). Overall, Par-3 appears to 
nucleate the recruitment of the Par complex proteins to TJs via binding to JAM molecules and 
is required for assembly and function of TJs. 
1.4.3 The stratum corneum: protein and lipid barrier 
Constant regeneration of the skin requires stem cells with almost unlimited mitotic potential in 
the basal layer which are subject to a complex series of differentiation scenarios during their 
upward journey towards the skin surface. Final differentiation outcome for keratinocytes in 
the suprabasal layer is the formation of the cornified envelope (CE). The CE formation is 
dependent on the expression of certain type of keratins in the suprabasal layer of the 
epidermis. This happens concomitant with extensive protein-protein and lipid-protein 
crosslinking activities mediated by transglutaminase enzymes that catalyze the formation of 
protein-protein epsilon-(gamma-glutamyl) lysine cross-links in ascending, differentiating 
keratinocytes. Crosslinking activity will culminate in the formation of a firm insoluble CE 
structure in epidermal surface. CE is composed of flattened cage like lipid coated structures 
containing keratin intermediate filaments, called corneocyte envelopes. Concerted with 
synthesis, deposition and crosslinking of CE proteins, the granular layer keratinocytes produce 
a diverse spectrum of specialized lipids that accumulate in vesicles entitled lamellar bodies. 
The lamellar bodies will finally fuse with the apical membrane of the topmost keratinocytes in 
the granular layer and exocytose their lipid content into the interface between the granular and 
cornified layers. The excreted lipids are crosslinked to the exterior face of the CE and also 
form the extracellular lipid sheets that surround the dead corneocytes. The corneocyte 
interconnection to each other and to the granulocytes via corneodesmosomal proteins in 
combination with extracellular lipid lamellae forms the functional barrier of the cornified 
envelope. The dead corneocytes will be peeled off in a process called desquamation or 
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shedding of the cornified cells in the most exterior zone of the skin (Reviewed by Candi et al., 
2005; Kalinin and Kajava, 2002; Sandhoff, 2010).  
1.4.3.1 Protein components of the cornified envelope  
There are a growing number of proteins which are being identified as components of the CE. 
The key proteins incorporated into CEs are Loricrin, Involucrin, Periplakin, Envoplakin, 
Small Proline-Rich proteins (SPRs), trichohyalin and late cornified envelope proteins (LCE). 
CE proteins have several shared features such as having highly basic isoelectric charge but 
each one show a distinctly unusual amino acid composition compared to the others. On the 
other hand, filaggrin-bound keratin intermediate filaments composed of keratin-1 and -10, and 
corneodesmosomal proteins such as desmoplakin are minor CE components (Steinert and 
Marekov, 1999). The majority of the CE structural proteins are encoded by a gene cluster 
region called the Epidermal Differentiation Complex (EDC) on human chromosome 1q21 
(Marenholz et al., 2001) and mouse chromosome 3 (Moseley and Seldin, 1989). Most of the 
genes within this region show similarity in their genomic structure and amino acid sequence. 
For instance loricrin, involucrin and SPRs show peptide sequence homology in their N- and 
C-terminal domains with enrichment of conserved Gln AND Lys residues. Additionally the 
exonal structure of involucrin, loricrin, most of SPR genes and LCE genes is similar. These 
genes comprise two exons with a single intron and the entire open reading frame is located in 
exon 2. The mentioned similarities have resulted in hypothesis that the genes within EDC 
region have diverged from a single ancestral gene by gene duplication. Subsequently the 
genes have evolved their unique characteristics through further gene duplications and DNA 
base change events (Backendorf and Hohl, 1992; Gibbs et al., 1993).  
1.4.3.2 Filaggrin gene and protein structure in humans and mouse 
Filaggrin or ‘filament-aggregating protein’ was first coined in 1981 to represent a class of 
structural protein isolated from the stratum corneum (Steinert et al., 1981). Human 
profilaggrin is encoded by the FLG gene within the EDC region on chromosome 1q21. The 
FLG gene comprises three exons and two introns (Presland et al., 1992; Markova et al., 
1993). Exon 1 is noncoding and protein translation starts within exon 2, while the bulk of 
profilaggrin protein is encoded by the large third exon (~12.5 kb). Human profilaggrin is a 
histidine-rich protein with MW of ~400 kDa which comprises between 10 and 12 tandemly 
oriented filaggrin repeats, which are flanked on both sides by two partial filaggrin repeats and 
by N- and C-terminal domains. Human filaggrin repeats are identical in size having 324 
amino acids and contain a short linker domain that is cleaved during conversion of the 
profilaggrin into active monomeric filaggrin (Gan et al., 1990; McKinley-Grant et al., 1989; 
Presland et al., 1992).  
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Mouse flg gene is located on chromosome 3 within EDC region and comprises two types of 
repeating units, type A and type B which are dispersed within gene sequence. In total 20 FLG 
repeats have been reported including 9 type A repeats and 11 type B repeats. Type A repeats 
(765 bps) encode 255 amino acids, whereas type B repeats (750 bps) encode peptides 
containing 250 amino acids (Rothnagel et al., 1994; Rothnagel and Steinert, 1990). Mouse 
profilaggrin is a short-lived large protein with MW >300 kDa consisting of multiple tandem 
repeats separated by a short 7-10 amino acid linker peptide (Dale et al., 1994). 
1.4.3.3 Filaggrin expression, function and processing 
       Profilaggrin is initially synthesized as a highly phosphorylated insoluble proprotein and is 
accumulated in keratohyalin granules in granular layer of epidermis. The early 
phosphorylation appears to prevent its premature binding to keratin filaments. The insoluble 
nature of the proprotein might facilitate its packing into keratohyalin granules. During 
cornification it is proteolytically cleaved in linker sites and dephosphorylated to release 
individual filaggrin monomers. Mouse monomeric FLG is ~26 kDa in size and is responsible 
for binding to intermediate keratin fibrils and aggregating them to keratin bundles in the 
cornified layer. The aggregation function of FLG would provide a model causing shape 
change of cornified keratinocytes from ellipsoid to flattened morphology. Altogether CE 
proteins, keratins and filaggrin contribute approximately 80-90% to dry mass of the 
epidermis. Furthermore, highly histidine-rich composition of FLG plays a key role in 
hydration of the skin, as processing of FLG into a mixture of hygroscopic compounds and 
their derivatives, such as pyrrolidone carboxylic acid (PCA), results in providing the natural 
moisturising factor (NMF) for the skin (Review by Candi et al., 2005). A novel role for FLG 
is protection against UV light; which comes from a study showing that mice deficient in a 
Caspase-14, a protease involved in proteolytic degradation of FLG resulted in increased 
sensitivity to UV damage (Denecker et al., 2007). 
Processing of profilaggrin to FLG occurs in several steps. It initiates with excision of the N-
terminus happening concurrently with processing of the poly-filaggrin sequence, first into 2-4 
filaggrin repeat intermediates and finally into mature (monomeric) FLG. Several 
endoproteases are known to engage profilaggrin processing, including calpain I (µ-calpain), a 
chymotrypsinlike enzyme, PEP1, furin or a related proprotein convertase (with specific 
involvement in cleavage of the N-terminus from profilaggrin), matriptase (MT-SP1), and the 
serine protease prostatin (CAP1/Prss8). Caspase-14 can cleave profilaggrin within the N-
terminal portion as well inside each filaggrin domain. Caspase-14 is specially important 
during final step in filaggrin degradation to free amino acids within the stratum corneum 
(Reviewed by Presland, 2009). 
       1.4.4 Lipid components of the cornified envelope  
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Barrier function of the cornified layer is conferred by conducive function of previously 
described proteins as well as lipid components including cholesterol, free fatty acids and 
ceramides. Major class of lipids in CE formation are ceramides, accounting for over 50% of 
the CE lipids. CE ceramides exist either as free unbound lipids in the extracellular lipid 
lamellae or lipids covalently crosslinked to proteins on the exterior face of the cornified 
envelope specially involucrin. Ceramides belong to the class of sphingolipids and display the 
greatest molecular heterogeneity in terms of sphingoid base and fatty acid composition. They 
are composed of a sphingoid base, sphingosine, phytosphingosine or 6-hydroxysphingosine 
which is N-acylated by a long-chain fatty acid. The lipids components of the extracellular 
matrix are synthesized by keratinocytes in the strata spinosum and granulosum and packed 
into disk-like, lipid membrane structures within specialized vesicles, called lamellar bodies. 
Lamellar bodies exocytose their content to the cell surface shortly before the keratinocytes 
transform into dead corneocytes. 
      Esterification of the ω-hydroxy group of ceramides with very long chain allows their covalent 
crosslinking to other lipids or CE proteins; as a result, they are either bound to long chain fatty 
acids, especially linoleic acid, or to glutamate residues of cornified envelope proteins 
(Sandhoff, 2010). 
       As precursor for epidermal ω-hydroxy ceramides and other lipids, epidermis also contains 
lower concentrations of corresponding ω-hydroxy glucosylceramides (GlcCers) which are 
also referred to as probarrier lipids. As a major step in the production of epidermal ceramides 
and in a process of extracellular lipid modification, free and protein bound ω-hydroxy 
GlcCers are degraded to ω-hydroxy ceramides. This conversion is mediated by β-
glucocerebrosidase (β-GlcCerase) and inactivation of either β-GlcCerase or its activator 
protein Prosaposin (pSAP) in the epidermis results in disturbed epidermal permeability barrier 
formation and reduced epidermal ceramide content (Doering et al., 1999-a, 1999-b).  
  1.5 The insulin-like growth factor (IGF) system 
1.5.1.1 IGF-1R and IGF-2R receptors and IGF binding proteins (IGFBPs)  
The evolutionarily conserved IGF system is involved in regulation of growth, proliferation 
and survival. The system operates through polypeptides; 1) IGF-1, IGF-2 and insulin, 2) the 
IGF binding proteins; 1-6, 3) the receptors; IGF-1R, IR, hybrid IR/IGF-1R, IGF-2R; and 4) 
IGFBP-proteases: IGF-1, IGF-2 and insulin polypeptides are highly homologous showing 
derivation from a common ancestral precursor hormone (Daughaday and Rotwein, 1989), 
(Reviewed by Denley et al., 2005; Rajpathak et al., 2009). IGF-I is predominantly synthesised 
in the liver and delivered to target tissues via systemic circulation (endocrine secretion), but 
based on its local production in most tissues, paracrine/autocrine signaling manner is also 
                                                                                                                                  Introduction 
 15
possible (Abbas et al., 2008). IGF-I has also been suggested to have a role in glucose and lipid 
metabolism by promoting peripheral uptake of glucose and protecting against insulin 
resistance (reviewed by Rajpathak et al., 2009).  
IGF-2 is a close relative of IGF-1 and according to both murine models and humans plays 
important roles during prenatal life by regulating the normal foetal growth and development 
(Chao and Amore, 2008). Systemically circulating IGF-2 is maintained in humans throughout 
life and is actually the predominant IGF in adult humans, the levels being 5-10-fold higher 
than IGF-1 (Frystyk, 2004). IGF-2 signal transmission occurs through binding to IGF-IR, with 
as high affinity as to its own receptor IGF-2R, and also through the IR isoform A to which it 
binds with equal affinity as insulin (Denley et al., 2004). For long time the assumed role for 
IGF-2R was modulation of IGF-2 bioavailability by internalizing and targeting IGF-2 for 
lysosomal degradation (Ellis et al., 1996); however, studies on endothelial progenitor cells 
from umbilical cord blood showed endothelial progenitor cells to have a high expression of 
IGF-2R, where IGF-2 and IGF-2R contributed in vasculogenesis at ischemic or tumour sites 
(Maeng et al., 2009).  
The level of free IGFs in the circulation is regulated by IGF-binding proteins (IGFBP) 1-6, 
mainly IGFBP-3, acting as IGF depot in the blood. IGFBPs control IGF bioavailability by 
forming complexes with IGFs, thereby extend their metabolic half-life and modulate the direct 
binding of IGFs to their receptors. IGFBP-3 as the most common IGFBP forms a ternary 
complex of 150 kDa together with each of IGF and the acid-labile subunit (ALS). In vivo the 
majority of IGF-1 and IGF-2 polypeptide pool is bound to IGFBPs and only less than 1% is 
free and bioactive (Frystyk, 2004). The IGF-1-IGFBP-3 complex extends the IGF-1 half-life 
in serum from 10 minutes to 12-15 hours by preventing IGF-I proteolysis (Rajpathak et al., 
2009).  
      1.5.1.2 Insulin 
Insulin is a key regulator of glucose metabolism by regulating glucose uptake and production 
and is also involved in other metabolic reactions such as lipolysis and protein synthesis. 
Insulin secretion from β-cells in the pancreas is stimulated by high blood glucose and amino 
acids. The central given function of activated insulin receptor is promoting glucose uptake in 
adipose tissue and skeletal muscles via translocation of the insulin responsive glucose 
transporter (GLUT4) to the cell surface (Saltiel and Kahn, 2001). In the circulation insulin is 
free, i.e. not bound to binding proteins which enables it to act quickly. Unlike IGFs, blood 
insulin level is prone to changes induced by glucose uptake, with high postprandial peaks in 
response to meals and low levels between meals and during the night (Frystyk, 2004). 
 
 
                                                                                                                                  Introduction 
 16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
   1.5.1.3 Structural homology of insulin receptor and IGF-1 receptor 
   The heterotetrameric membrane glycoproteins, insulin receptor (IR) and IGF‐1 receptor 
(IGF‐1R) belong to the tyrosine kinase family and show 84% homology in the β‐subunit of 
tyrosine kinase domains. Unlike other receptor tyrosine kinases, which are activated by ligand 
dimerization, IR and IGF‐1R are already dimerized at the cell surface as a tetramer composed 
of two disulphide‐linked αβ‐dimers, where each αβ‐dimer consists of an extracellular α‐subunit 
and a transmembrane β‐subunit (Ullrich et al., 1986). The extracellular α‐subunits of the IR 
and IGF‐IR contain six structural domains, of which ligand-binding determinants have been 
localized to the L1, cysteine-rich and L2 domains and to the C-terminal peptide sequence. 
β‐subunits as intracellular domains of the receptor are the parts which are tyrosine 
phosphorylated and subsequently transduce the signal (Benyoucef et al., 2007). 
   1.5.1.4 Hybrid insulin receptor/IGF-1 receptor 
   Given the close homology between IR and IGF-1R, in tissues with normal expression of each 
single receptor, hybrid IR/IGF-1R receptors (HR) are known to form by random assembly of 
receptor hemidimers consisting of one IR αβ-dimer and one IGF-1R αβ-dimer (Moxham et 
al., 1989; Soos and Siddle, 1989). Hybrid receptors have been demonstrated in many tissues 
Figure 5: Schematic representation of the IGF system. The IGF system consists of the receptors 
(IGF-1R, two IR isoforms, IGF-1R:IR hybrids and IGF-2R), the peptides (IGF-I, IGF-II and 
insulin) and six high affinity IGFBPs. IGFs circulate mainly in an IGF:IGFBP-3:ALS complex. 
Release of IGFs from IGFBPs occurs upon IGFBP proteolysis or extracellular matrix (ECM) 
binding. IGFBPs can also act independently of IGF entering the cell via as yet undefined receptors. 
IGF-2R modulates the bioavailability of IGF-II (adapted from Denley et al., 2005). 
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including skeletal muscle, adipose tissue, placenta, breast cancer cells and osteoblasts. 
(Reviewed by Arnqvist, 2008; Frasca et al., 2008). Studies carried out with purified hybrid 
receptors suggest that these receptors mostly bind IGF-1, while they bind insulin with a much 
lower affinity (Soos et al., 1993; Pandini et al., 1999) although their roles in cellular responses 
remain unclear and present a challenge to IGF/insulin researchers (Fig.6). 
 
 
 
 
 
 
 
 
 
 
 
 
1.5.1.5 Activation of receptors and signaling pathways 
First step in the initiation of biological effects of insulin, IGF-1 and IGF-2, is binding to their 
receptors, IGF-1R, IR or hybrid IR/IGF-1R. The putative ligand binding pockets are located 
in the cysteine rich portion of the extracellular α subunits whereas the β subunit contains 
tyrosine kinase domain, ATP and substrate binding pockets and autophosphorylation sites (De 
Meyts and Whittaker, 2002).  
Insulin/IGF-1 ligand binding will cause a conformational change in the receptor structure 
which will bring the receptor domains close together and initiate autophosphorylation of 
several tyrosine residues on the β-subunits. IGF-1R and IR demonstrate overlap in directing 
downstream signaling events, the critical nodes being IRS proteins 1-4, phosphatidylinositol 
3-kinase (PI3K) and Akt in the PI3K-pathway which is generally considered to be responsible 
for most of the metabolic effects, and Erk 1/2 in the Ras mitogen-activated protein kinase 
(MAPK) pathway which in cooperation with the PI3K-pathway control mitogenic and 
differentiation responses (Taniguchi et al., 2006).  
The downstream Akt pathway is activated by mTOR to ensure both a reasonable level of 
nutrients and a positive signal for cell growth and division. The binding of IGF-1 to its 
tyrosine kinase receptor (IGF-1R) results in the recruitment of the PI3 kinase (PI3K) to the 
plasma membrane and its activation. PI3K, in turn, phosphorylates the phosphoinositides, 
increasing the concentration of PIP3 at the plasma membrane. Increased PIP3 activates PDK1 
Figure 6: Schematic representation of hybrid receptors. In cells and tissues expressing both IR 
and IGF-1R, IR hemireceptors may heterodimerize with IGF-1R hemi-receptors, leading to the 
formation of hybrid IR/IGF-1Rs (HRs), which bind IGF-1 and IGF-2 with high affinity and insulin 
with a much lower affinity (adapted from Frasca et al., 2008). 
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and mTORC2 (PDK2). The resultant phosphorylation of Akt on Thr308 by PDK1, and on 
Ser473 by mTORC2, respectively, leads to the full activation of Akt. Akt then phosphorylates 
several cellular proteins, including FOXO transcription factors, BAD, MDM2, and GSK3α/β 
to facilitate cell survival and cell cycle entry. The IGF-1/ Akt pathway regulates mTORC1 
through Akt phosphorylation of TSC2 on multiple sites; this inhibits the TSC2 GTPase 
activity, resulting in the activation of Rheb and mTORC1. This coordination of IGF1/ Akt and 
mTOR pathways enables the activation of mTOR that in turn promotes cell growth in 
response to the stimulation of growth factors, including insulin and IGF-1 (Reviewed by Feng 
and Levine, 2010). Therefore IR/IGF-1R signaling will result in the regulation of cell 
metabolism, proliferation, and survival (Baserga and Hongo, 1997; Pollak, 2008), depending 
on cell type (Fig.7).  
1.5.2 Insulin signaling in diabetes and gene knockout models for IR/IGF-1R  
      In pathological condition of diabetes mellitus type 2, insulin insensitivity occurs which is due 
to decreased insulin receptor signaling and leads to abrogated glucose take up in insulin target 
tissues resulting in increased circulating glucose or hyperglycemia (Clauser, 1994). 
Mice lacking insulin receptors are born with normal visible parameters but develop early 
postnatal diabetes and die of ketoacidosis (Accili et al., 1996). On the other hand inherited 
mutations nullifying the human IR gene, result in severe intra-uterine growth retardation, 
failure to thrive, and hypoglycemia which indicates that insulin receptor also promotes 
embryonic growth (Reviewed by Kitamura et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: scheme showing IR/IGF-1R signaling pathway. Insulin/IGF-1 ligand binding to the 
IR/IGF-1R leads to autophosphorylation on different tyrosines in the kinase domain, followed by 
recruitment of IRS-1 and PI3K activation. This interaction leads to recruitment and activation of 
phosphoinositide dependent kinase-1 (PDK1) and AKT/protein kinase B via phosphatidylinositol 
3, 4, 5-triphosphate (PIP3) production. Another pathway activated through IRS-1 signaling is the 
MAPK pathway. Downstream molecules in IR/IGF-1R axis have diverse roles in promoting 
growth, proliferation, differentiation and protection against apoptosis. 
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The knowledge about mammalian IGF-1R in development was obtained from analysing the 
IGF-1R null mice. IGF-1R knockout mice have 45% of the size of their wild type siblings at 
birth and die shortly after birth due to severe organ hypoplasia (Liu et al., 1993). Cultured 
IGF-1R-/- fibroblasts showed slower growth compared to wild-type fibroblasts and were not 
able to proliferate under anchorage-independent conditions (Sell et al., 1993). Together with 
IR, skeletal muscle also shows abundant expression of IGF-IR that can enhance muscle 
glucose uptake via mobilisation of GLUT-4. Inactivation of IGF-IR in skeletal muscle in mice 
causes severe insulin resistance and type 2 diabetes at an early age, implicating an important 
function for IGF-I in glucose homeostasis (Fernandez et al., 2001).  
1.6 Regulation of endothelial function by Insulin/IGF-1 signaling and in Diabetes 
1.6.1 Role of IR and IGF-1R signaling in endothelial cells 
Endothelial insulin and IGF-1 signaling pathways alone do not appear to play an essential role 
in the normal development of retinal vasculature and vascular barrier function under steady 
state homeostasis conditions. In vivo inactivation of mouse IR or IGF-1R genes had no major 
consequences on vascular development or glucose homeostasis under basal conditions (Vicent 
et al., 2003). However, early postnatal hypoxia stimulation to induce artificial retinal 
neovascularization in mice with either endothelial specific inactivation of IR or IGF-1R 
resulted in 57% and 34% reduction of neovascularization areas respectively (Kondo et al., 
2003). This is suggestive of the central role of insulin and IGF-1 signaling under challenging 
hypoxia conditions. In contrast to the stimulatory effect of IGF-1 signaling in the development 
of retinopathy in mice (Kondo et al., 2003), human preterm infants born with low levels of 
IGF-1 in their serum show a higher risk of developing retinopathy of prematurity (ROP), a 
hypoxia induced pathological neovascularization in retina (Heidary et al., 2009). Intraocular 
overexpression of IGF-1 ligand in transgenic mouse models contributed to accumulation of 
VEGF and BRB breakdown, marked by increased vessel paracellular permeability to mannitol 
(182 Da) and HRP (44 kDa) (Haurigot et al., 2009). IGFBP-3 as key regulator of IGF-1 
activity is seen to be significantly increased in neovascular tufts of the OIR retina, suggesting 
the local regulatory functions of IGFBP-3 in the retina (Lofqvist et al., 2009).  
Angiogenesis response in healing skin wounds that leads to the formation of new blood 
vessels in the wound bed is driven by hypoxia (Wattel et al., 1990). Wound healing procedure 
is significantly impaired in diabetic wounds resulting in decreased time of closure. Following 
the role described for IGF-1 signaling in retinal neovascularization and vascular leakage, it is 
an open question if disturbed insulin/IGF-1 signaling in endothelial cells can underlie the 
defective wound healing response seen in diabetic patients.    
1.6.2 Blood-retinal-barrier breakdown in diabetes 
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Increased vascular permeability associated with angiogenesis underlies the pathology of 
diabetic retinopathy (DR) in type 1 diabetic patients. DR is a late onset complication of 
diabetes and is the major cause of vision loss in the working age population in developed 
countries. On the other hand excessive edema due to the breakdown of the BRB is the main 
event involved in the pathogenesis of diabetic macular edema (DME) seen in type 2 diabetic 
patients (Reviewed by Simó et al., 2010). Despite reported increase of intraocular IGF-I levels 
in diabetic patients, the induction switch for such IGF-1 elevation and the source of IGF-I 
production is not clear (Haurigot et al., 2009). Nevertheless, studies with systemically infused 
small molecular weight tracers have shown leaky interendothelial cell tight junctions in retinal 
vessels of diabeteic rats and dogs (Wallow and Engerman, 1977; Ishibashi et al., 1980) 
indicating uncontrolled fluid diffusion through disrupted endothelial TJs in diabetic 
retinopathy.  
The development of DR is hypothesized to be at least in part driven via elevated intraocular 
VEGF expression. VEGF induced vascular permeability is accompanied with rapid 
phosphorylation of the intracellular tail of VE-cadherin leading to its endocytosis and 
disruption of the endothelial barrier function (Gavard and Gutkind, 2006). 
Elevated MMP-mediated proteolytic degradation of endothelial type VE-cadherin and 
reduction in its transcript levels is seen in retinal vessels of streptozotocin-induced diabetic 
rats which was coincident with increase in retinal vascular leakiness (Navaratna et al., 2007). 
Similar to interrupted VE-cadherin expression and processing, reduction in cadherin-5 is 
presumably another landmark of leaky endothelial junctions in DR (Davidson et al., 2000).  
Occludin as an integral TJ protein is reportedly target for deregulation in retinal vessels from 
DR. For instance, rats with STZ-induced chronic diabetes represented decreased occludin 
content and immunostaining at cell junctions parallel with increased BRB permeability 
(Harhaj et al., 2006). Similar change in occludin content was also recapitulated in vitro by 
VEGF treatment of bovine retinal endothelial cells. VEGF mediated reduction in occludin 
level depends on urokinase plasminogen activator suggestive of increased extracellular 
proteolytic activity contributing to occludin degradation and probably vascular barrier 
breakdown (Harhaj et al., 2006). Affirmatively in vivo immunohistochemical analysis has 
shown inverse relationship between occludin immunoreactivity signal and the degree of 
vascular permeability in the retina of STZ-induced diabetic rats or in non-diabetic rats with 
intravitreal VEGF-injection (Barber and Antonetti, 2003). However the authors reported no 
change in immunoreactivity signal for cldn-5 which is the main cldn type present in 
endothelial intercellular junctions. Therefore changes in occludin content, phosphorylation 
and localization accompanied by alterations in barrier properties seen in DR substantiates the 
key role of occludin in the maintenance of BRB.  
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In addition to impaired cell-cell junctions, abnormal transendothelial vesicular transport 
(Hofman et al., 1999) and endothelial cell apoptosis (Mizutani et al. 1996; Joussen et al., 
2001) have also been shown to underlie increased retinal vascular permeability in DR. It is 
possible that endothelial cell death would be the key disturbance accounting for major retinal 
vascular leakage in diabetes as suppression of endothelial apoptosis is presented as a potent 
approach to prevent BRB breakdown in STZ-induced diabetic rats (Joussen et al., 2003). 
      1.7 Role of insulin/IGF-1 signaling in the skin 
       Keratinocytes of human skin express both insulin and IGF-1 receptors, but they do not 
synthesize IGF-1 or insulin ligands (Barreca et al., 1992; Tavakkol et al., 1992). Dermal 
fibroblasts could support the proliferation of keratinocytes in the epidermis by secreting IGF-1 
and insulin (Barreca et al., 1992; Tavakkol et al., 1992). Epidermal inactivation of mouse IR 
showed a very subtle reduction in skin thickness while IGF-1R gene deletion resulted in an 
obviously thinner epidermis. Both type of these knockout mice were viable while deletion of 
both epidermal IR and IGF-1R genes resulted in translucent and shiny skin culminating in 
early prenatal lethality within few hours after birth (Stachelscheid et al., 2008). However the 
underlying reason leading to lethality in these mice awaited clarification.  
      Consistently, inactivation of IGF-1R signaling components such as IGF-1R, IGF-1 and/or 
IGF-2 (Liu et al. 1993), Insulin receptor substrate 1 (IRS1) (Sadagurski et al., 2007) or both of 
the downstream kinases AKT1 and AKT2 (Peng et al., 2003) in mice each resulted in a 
disturbed epidermal stratification, generating hypomorphic epidermis although the exact 
downstream regulators in the pathway are yet unclear. 
      As an expected role for a growth factor, transgenic mice with overexpression of either IGF-1 
or IGF-2 in the basal layer of epidermis, represented epidermal hyperplasia, hyperkeratosis 
and squamous papillomas (Bol et al., 1997; DiGiovanni et al., 2000; Bennett et al., 2003). 
This observation could link IGF-1R signaling in skin to carcinogenesis. 
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Aims of this study  
The overall goal of this thesis was to analyze the role of cell autonomous insulin/IGF-1 signaling 
in the regulation of in vivo barriers with a focus on vascular endothelial and epidermal skin barrier 
function.  
 
Specifically, the following specific aims were addressed: 
 
1. To determine the cause underlying early prenatal lethality of dkoepi-/- mice 
2. Does the loss of epidermal IGF-1R and IR affect epidermal outside-in and inside-out barrier 
formation? 
3. Which molecular components of the outside-in and inside-out barriers are perturbed in the 
absence of epidermal insulin and IGF-1 signaling? 
4. Does IR/IGF-1R signaling regulate vascular barrier function in the adult retinal vasculature?  
5. Generate a tissue specific inactivation mouse model for the polarity protein Par3, a downstream 
component of IR/IGF-1R, which regulates tight junctional barrier formation in vitro.  
 
To this end we generated either epidermal specific knockouts for IR and IGF-1R, using K14-Cre 
mice, as well as inducible vascular endothelial specific knockouts for IR and IGF-1R, using 
Tie2CreERT2 and analysed barrier function.  
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Figure 8: Increased transepidermal water loss in dkoepid-/- mice. (A) Average TEWL measurements ± S.D. 
of Ctrl (n=7) and dko (n=5). For each mouse, 15 highest steadfast values were measured and then all mouse 
values were pooled. (B) Total distribution of the 15 highest TEWL values ± S.D. per mouse of either control 
(Ctrl) or dkoep-/- mice. (*) indicates P value summary of F test to compare variances.  
2.1.1 Increased levels of epidermal water loss in epidermal deficient IR/IGF-1R mice 
Inactivation of both the insulin receptor (IR) and IGF-1R receptor (IGF-1R) in the epidermis of 
mice (dkoepi-/-) using Cre-loxp technology with Cre driven by the K14-promotor resulted in 
perinatal lethality within the first day after birth. These mice were born with a thin and translucent 
skin that is slightly shiny compared to control mice (Stachelscheid et al., 2008). This suggested 
that the skin barrier might be compromised in the absence of epidermal IR/IGF-1R signaling. To 
directly test if newborn dkoepi-/- mice showed increased loss of water compared to their control 
siblings, transepidermal water loss (TEWL) measurements were performed. An approximately 
two-fold increase in water loss was observed in dkoepi-/- in comparison with control mice (Fig.8), 
which suggests that dehydration is the primary cause of lethality in dkoepi-/- mice.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
2.1.2 Insulin/IGF-1 signaling might be essential for competent inside-out epidermal 
barrier formation 
To examine if increased inside-out permeability of the skin also contributed to the observed water 
loss in dkoepi-/- mice, newborn mice were dermally injected with amine reactive biotin and its 
diffusion across different layers of the epidermis was assessed. Biotin diffusion is normally only 
observed only up till the stratum granulosum, the layer that contains the functional tight junctions 
and thereby restrict diffusion into the stratum corneum (Furuse et al., 2002; Tunggal et al., 2005). 
As expected, in many areas in our control mice biotin staining was observed only in the viable 
layers of the epidermis with a sharp demarcation where the tight junctions were, visualized by 
ZO1 (Fig.9A, arrows). However, in a few positions biotin staining was observed above the tight 
A B 
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 Figure 9: Assessment of the inside-out barrier function in ctrl and dkoepi-/- mice (A) Biotin 
diffusion assays. (A) Biotin was injected subcutaneously under back skin. Biotin in cryo sections 
was detected with Alexa-488 conjugated Streptavidin. Marked by yellow arrows, ZO-1 
immunostaining demarks the site of tight junctions in the granular layer. (B) Cldn-1 
immunostaining in the epidermis of Ctrl and dko mice. C. Western blot shows the levels of Cldn-1 
in Ctrl and EDKO mice.  Bar= 20 µm. 
 
junctions (Fig.9A, arrow head). This suggested that the skin barrier of control mice was slightly 
compromised in these sections, perhaps due to scratching of mice. In sections examined of dkoepi-/- 
mice very little staining was visible in the epidermis, suggesting that within these sections little 
biotin had diffused into the epidermis as compared to those of control where biotin staining 
revealed an intercellular distribution in the viable layers of the epidermis (Fig.9A). Although 
some faint biotin staining was positive above the tight junctions in the granular layer, it was 
unclear if this was specific or not. Overall, the result made the experiment hard to interpret and 
will require a repetition of the experiment and further functional analysis if the inside-out barrier 
was perturbed upon loss of IR/IGF-1R.   
 To examine if loss of IR/IGF-1R in the epidermis alters the localization of claudin-1, a tight 
junctional membrane component that contributes to tight junctional strand formation and is crucial 
for skin barrier function (Furuse et al., 2002), immunofluorescence analysis was conducted.  All 
suprabasal layers showed staining at sites of cell-cell contacts with no obvious difference between 
control and dkoepi-/- mice (Fig.9B).  In addition, WB analysis of epidermal lysates did not reveal 
any difference in cldn-1 protein expression (Fig.9C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.3 Insulin and IGF-1 signaling regulate outside-in epidermal barrier formation 
DKO 
Cldn-1 
actin 
A B 
C 
Ctrl Dkoepi-/- 
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In order to investigate the integrity of the outside-in barrier in dkoepi-/- mice, toluidine blue dye 
penetration assay were done on E16.5-18.5 embryos and P0 mice (Hardman et al., 1998). Control 
E16.5 mice showed penetration of toluidine blue at the ventral side whereas only patched staining 
was observed at the dorsal or back skin, indicating partial acquisition of barrier (Fig.10A). One 
day later, E17.5, the back skin was completely impermeable to toluidine blue indicating a 
functional outside-in barrier, whereas the ventral side now showed a partial penetration. At E18.5 
almost all of the skin of control mice was impermeable to toluidine blue except for some ventral 
patches. Newborn control mice showed no staining for toluidine blue indicating a fully developed 
outside-in barrier. Such a gradual developmental acquisition of the outside-in barrier has been 
reported previously (hardman et al., 1998: Tunggal et al., 2005). In contrast, no functional 
outside-in barrier could be observed at E16.5 dkoepi-/- embryos, as shown by complete penetration 
of toluidine blue (Fig.10A). In E17.5 dkoepi-/- embryos were almost completely penetrated by 
toluidine blue with the exception of very small patches at the back skin, suggesting an impaired 
and strongly delayed formation of the epidermal barrier. This was further confirmed in E18.5 dko 
embryos in which the complete ventral and a significant part of the back skin were still stained by 
toluidine blue. However, newborn dkoepi-/- mice were impermeable to the dye with exception for 
small spots near the whisker follicles and randomly distributed over the body (Fig.10A). To 
confirm proper outside-in epidermal barrier formation in P0, as shown by complete toluidine blue 
exclusion in dkoepi-/- mice, lucifer yellow (LY) penetration was tested through the back skin of the 
viable mice which differs from toluidine blue procedure where the skin is not fixed in LY 
protocol. In both control and dkoepi-/- mice, lucifer yellow was arrested in the superficial layers of 
stratum corneum and did not show penetration to deeper epidermal layers (Fig.10B). Overall 
these experiments indicates a strongly delayed formation of the functional outside-in barrier, 
suggesting either a developmental delay in the formation of a fully functional stratum corneum or 
an impaired formation of the stratum corneum that later is partially restored by compensatory 
mechanisms.   
2.1.4 Abnormality in corneocyte morphology and size in dkoepi-/- mice 
Delayed outside-in barrier formation in dkoepi-/- mice indicated disturbance in stratum corneum 
function. Therefore, corneocytes, as major constituents of SC, were isolated from the E18.5 
embryos, newborns and adult IGF-1Repi-/- mice for microscopic analyses in order to reveal any 
abnormality in shape and size. Based on microscopic morphology, corneocytes from age matched 
ctrl and dko groups in E18.5 and P0 were similar in size and roundness (Fig.11A). Due to the fact 
that dkoepi-/- mice showed early prenatal lethality, it was not possible to analyse the adult 
corneocytes; therefore, based on the previous description by Stachelscheid and coworkers (2008), 
IGF-1Repi-/- mice demonstrated thinner epidermis compared to IRepi-/- mice, which indicated that 
IGF-1 signaling played a more critical role in epidermal morphogenesis. Therefore, adult IGF- 
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Figure 10: Delayed outside-in epidermal barrier formation in dkoepi-/- mice. (A) Embryos in 
gestational ages E16.5, 17.5 and 18.5 and in newborn mice (P0) were fixed with methanol and stained 
with toluidine blue. (B) The penetration of LY dye in the epidermis of P0 mice is shown for control 
and DKO mice on cryo sections. Samples were counterstained with Phalloidin to visualize actin 
cytoskeleton. Bar=20 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Repi-/- corneocytes were analysed. Interestingly isolated IGF-1Repi-/- corneocytes were more 
heterogenous in shape compared to that of control ones (Fig.11B), showing the importance of 
IGF-1 signaling in corneocyte production in adult skin. In order to quantify any variation in 
corneocyte appearance between ctrl and dko mice, two important features of corneocytes, i.e., size 
and circularity indices were investigated. Objects with circularity index closer to 1 are more 
circular and hence reflecting the extent of the compactness of an object. Embryonic dkoepi-/- E18.5 
corneocytes were smaller (Fig.12A) and less circular (Fig.12B) compared to those of their control 
littermate corneocytes. 
 
 
 
 
E16.5                   E17.5                    E18.5                             P0         
            
   dkoepi-/- 
   Ctrl 
LY 
Phalloidin 
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  Ctrl     dkoepi-/- 
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B, circularity 
 
Figure 11: Microscopic view of the corneocytes isolated from E18.5 embryos, P0 and adult wild type 
and IGF1Repi-/-knockout mice. Corneocytes were isolated from the ears following SDS-DTT boiling 
protocol and resuspending in Tris/EDTA buffer for imaging by light microscope. Bar= 30 µm.  
A, size 
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In P0 corneocytes while there was not highly significant difference in circularity index between 
the experimental samples (Fig.13B), there was significant variation in the size of corneocytes as 
Figure 12: Corneocyte area and circularity index in Ctrl and dkoepi-/- E18.5 embryos. (A) Left, 
distribution of size index. For each mouse 100 corneocytes were analysed by area function of ImageJ 
software. Right, the measured values for two control and two dkoepi-/- mice are pooled. Results are means ± 
S.D (B) Left, distribution of circularity index. For each mouse 100 corneocytes were analysed by circularity 
function of ImageJ software. Right, the measured values for two control and two dkoepi-/- mice are pooled. 
Results are means ± S.  (*) indicates P value summary of F test to compare variances.  
dko 
E18.5 P0 
Ctrl 
IGF-1Repi-/-                           Ctrl    
Adult 
B A 
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B, circularity 
 
dkoepi-/- samples were bigger and showed a high level of heterogeneity in size distribution 
compared to controls (Fig.13A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corneocytes isolated from adult IGF-1Repi-/- mice showed no difference in circularity index 
compared to those of control samples (Fig.14B) but they were larger and provided a broad 
distribution in size distribution, hence considered to be heterogeneous in respect with size values 
(Fig.14A).  
 
2.1.5 Aberrant profilaggrin to filaggrin processing in dkoepi-/- mice  
Following documentation of the disturbances in outside-in and corneocyte envelopes in knockout 
mice, it was decided to evaluate the expression of the late differentiation markers, filaggrin, 
loricrin and involucrine by WB analysis and immunolocalization.  
There were no obvious differences in the expression levels of loricrin, involucrin (Fig.15A) and 
filaggrin (Fig.15B) in the epidermis of E18.5 control and dkoepi-/- embryos (Stachelscheidt et al., 
2008).  However, protein levels of the final processed form of monomeric 26 kDa filaggrin was 
dramatically reduced in dkoepi-/- E18.5 and P0 epidermis (Fig.15B). The reduction of filaggrin was 
very striking as this monomeric form is essential for collapsing keratin bundles in the epidermis 
Figure 13: Corneocyte area and circularity index in Ctrl and dkoepi-/- P0 embryos.  (A) Left, distribution 
of size index. For each mouse 100 corneocytes were analysed by area function of ImageJ software. Right, 
the measured values for two control and two dkoepi-/- mice are pooled. Results are means ± S.D (B) Left, 
distribution of circularity index. For each mouse 100 corneocytes were analysed by circularity function of 
ImageJ software. Right, the measured values for two control and two dkoepi-/- mice are pooled. Results are 
means ± S.  (*) indicates P value summary of F test to compare variances. 
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(Lynley and Dale, 1983), suggesting that failure in epidermal filament aggregation could 
contribute to the major barrier defect observed in dkoepi-/- mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Caspase-14 has been identified as an important protease involved in filaggrin processing 
(Denecker et al., 2007). Due to the reduction of monomeric filaggrin in dkoepi-/- mice, the question 
was raised to see if abnormal filaggrin processing in dkoepi-/- mice was caused by altered Casp-14 
expression or activation. No change was seen in the levels of the non-active (33 kDa form) and 
activated Casp-14 (p10/p20 isoforms) in E18.5 epidermal samples (Fig.15C). This data implies 
that IR/IGF-1R signaling does not regulate the expression of Casp-14 in mouse epidermis and 
aberrant filaggrin processing in dkoepi-/- mice was not caused by impaired Casp-14 activation. 
Therefore other filaggrin-processing proteases may be responsible to adverse affect occurring in 
dkoepi-/- epidermis. 
 
 
 
Figure14: Corneocyte area and circularity index in Ctrl and IGF-1Repi-/- adult mice. (A) 
Left, distribution of size index. For each mouse 100 corneocytes were analysed by area 
function of ImageJ software. Right, the measured values for two control and two IGF-1Repi-/- 
mice are pooled. Results are means ± S.D (B) Left, distribution of circularity index. For each 
mouse 100 corneocytes were analysed by circularity function of ImageJ software. Right, the 
measured values for two control and two IGF-1Repi-/- mice are pooled. Results are means ± S. 
ns: not significant. (*) indicates P value summary of F test to compare variances. 
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To check whether deletion of IR/IGF-1R in the epidermis affected the localization of terminal 
differentiation markers filaggrin, loricrin, involucrin and casp-14, immunofluorescence was 
performed using corresponding antibodies. 
p 10 
p 20 
casp-14 
Figure 15: Expression levels of loricrin, involucrin, filaggrin and casp-14 in the 
epidermis of ctrl and dkoepi-/- mice. (A) Expression of loricrin and involucrin in the 
epidermis of ctrl and dkoepi-/- E18.5 and P0 mice. (B) Expression and processing of 
profilaggrin to filaggrin in E18.5 and P0 epidermis. Asterisks mark the final cleaved 
filaggrin monomer. (C) Expression of non-active (33 kDa) and active (11, 17 kDa) 
casp-14 in E18.5 epidermis. Actin is loading control. 
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Filaggrin signal was detected in the epidermis in E17.5 and there was no discernible difference in 
the punctuate labelling of the epidermal keratohyalin granules in the granular layer of the 
epidermis which harbour the precursor proprotein profilaggrin. The apparent reduction in the 
stained granular stacks is due to the thinner epidermal formation in the dkoepi-/- mice. The increase 
in the intensity of the filaggrin signal from E17.5 to P0 is overlapping with the epidermal barrier 
function recovery which was shown with toluidine blue dye penetration assay (Fig.16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For casp-14, a staining pattern similar to filaggrin was observed. Except in E16.5, positive 
cytoplasmic diffuse signal was seen in the epidermis of control and dkoepi-/- mice. Similar to 
filaggrin staining in the corresponding embryonic age E18.5, casp-14 revealed punctuate 
cytoplasmic staining in the epidermis of both dkoepi-/- and control samples. This data suggested 
Ctrl Ctrl dkoepi-/- dkoepi-/- 
filaggrin 
 
casp-14 
E-16.5 
E-17.5 
E-18.5 
Figure 16: Immunolocalization of filaggrin and casp-14 in the epidermis of E16.5, 17.5, 18.5 and 
P0 control and dkoepi-/- mice. Paraffin sections were counterstained with DAPI to distinguish the nuclei 
following immunolabelling with respective antibodies. Dashed line marks the basal layer. Bar= 20 µm. 
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casp-14 localization in keratohyalin granules which was converted again to cytoplasmic labelling 
in newborn P0 mice and extended to lower spinous layer as well, while filaggrin staining was 
mainly restricted to keratohyalin granules in granular layer (Fig.16).  
Both control and dkoepi-/- mice provided a very similar immunofluorescence signal for loricrin, a 
major crosslinked epidermal protein which accounts for up to 60%-80% of total protein 
composition of the cornified envelop (Steinert and Marekov, 1995) in both ctrl and dkoepi-/- mice 
for all the time points. Together with WB results shown for loricrin (Fig.15A), insulin/IGF-1 
signaling is not likely to be required for loricrin expression in the epidermis (Fig.17). Involucrin 
staining was seen in the granular layer and showed a similar pattern during E17.5, E18.5 and 
newborn epidermis but was absent from dkoepi-/- epidermis in E16.5 stage which might be linked 
to severe epidermal barrier abnormality in dkoepi-/- mice (Fig.17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ctrl dkoepi-/- dkoepi-/- 
loricrin involucrin 
Ctrl 
E-16.5 
E-17.5 
E-18.5 
Figure 17: Immunolocalization of loricrin and involucrin in the epidermis of E16.5, 17.5, 18.5 
and P0 control and dkoepi-/- mice. Paraffin sections were counterstained with DAPI to distinguish 
the nuclei following immunolabelling with respective antibodies. Dashed line marks the basal 
layer. Bar= 20 µm. 
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2.1.6 Reduced epidermal ceramides in dkoepi-/- mice 
Owing to the observed clear delay in the outside-in barrier formation demonstrated with toluidine 
blue penetration in dkoepi-/- mice and high amount of epidermal water loss observed in newborn 
dkoepi-/- mice, question was raised if Insulin/IGF-1 signaling regulated lipid composition of the 
outer epidermis. Therefore, unbound free extractable lipids from stratum corneum of control, 
IRepi-/- and dkoepi-/- mice were analysed by Thin Layer Chromatography (TLC). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As dkoepi-/- mice had a thinner epidermis compared to control mice, less lipid could be extracted 
from their epidermis, thus in order to obtain an equal loading amount of 2.6 mg, the stratum 
corneum extracts of three dkoepi-/- mice were pooled together.  There was an obvious reduction in 
Figure 18: Analysis of free extractable epidermal lipids by TLC. (A) TLC of crude epidermal extracts. The 
levels of Cer (C24/C26 NS), Cer (C16/C18 NS) and Cer (NP) are significantly reduced in the dkoepi-/- samples. 
For the control and IRepi-/- mice samples from every single mouse were loaded. Dkoepi-/- samples represent 
pooled lipid extracts from 3 mice (B) The quantification of the various ceramides. Data are represented as 
means ± S.D. of 6 control, 4 IRepi-/-, and 2 DKO replicates. 
dkoepi-/-    IRepi-/-       Ctrl        Ctrl         Ctrl        Ctrl 
A 
B 
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the intensity of the lipid bands for ceramides, Cer(C24/C26 NS), Cer(C16/C18 NS) and Cer(NP) 
in the stratum corneum of newborn dkoepi-/- mice (Fig.18A) compared to those of IRepi-/- and 
control mice. IRepi-/- mice also exhibited a mild reduction in the amount of Cer (C24/C26 NS), Cer 
(C16/C18 NS) ceramides.  
According to the statistical quantification of total extracted cornified layer ceramides there is 
almost 40% reduction in the amount of Cer(C16/C18 NS) and two fold reduction in the levels of 
Cer(C24/C26 NS) in dkoepi-/- mice compared to those of control animals (Fig18B). 
Levels of glucosylceramides (GlcCers), the so called pro-barrier lipids, which are considered to 
function as key component of the epidermal lipid barrier (Jennemann et al., 2007), were elevated 
in dkoepi-/- mice compared to those of control mice. This data may reflect a defect in ceramide 
procressing in these mice as GlcCers are considered to be the major source for ceramide 
production in mouse epidermis (Doering et al., 2002). 
Dkoepi-/- mice provided critical reduction in the levels of epidermal ceramides. Corneocytes are 
surrounded by a cornified cell envelope made up of proteins, mainly loricrin and involucrin. 
Specially involucrin in the corneocytes is a known to covalently bind to the hydroxyceramide 
lipid molecules (Candi et al., 2005). As demonstrated previously by WB analysis, the reduced 
ceramide levels did not influence involucrin expression in the dkoepi-/- epidermis in P0 (Fig.15A). 
This means that involucrin expression or stability is not dependent on proper ceramide deposition 
in the epidermis. 
2.1.7 Impairment of tight junctions in cultured IGF-1R-/- keratinocytes  
Abnormal diffusion of subcutaneously injected biotin above the granular layer to the cornified 
layer in dkoepi-/- mice followed with exceedingly high amounts of epidermal water loss in these 
mice provided critical evidence about malfunction of epidermal tight junctions in vivo.  
To further assess whether IGF-1R regulates tight junctional barrier formation, the in vitro Ca2+ 
switch model was used to analyse barrier formation in primary keratinocytes isolated from control 
and IGF-1R-/- epidermis. These cells are normally cultured under low Ca2+ conditions to prevent 
terminal differentiation. Increase of Ca2+ in the medium does not only trigger differentiation, but 
also induces intercellular junction formation and stratification by allowing the Ca2+ dependent 
engagement of cadherins (Michels et al., 2009a-b). 
The measurement of transepithelial electrical resistance (TER) allows following the proper tight 
junction-mediated sealing of the paracellular space over time, thus assessing TJ function. 
Whereas control keratinocytes successfully elevated the levels of TER after Ca2+ switch, IGF-1R-/- 
keratinocytes showed an almost 50% reduction in TER, suggesting impairment of TJ function TJ 
(Fig.19B).  
 
 
                                                                                                                                  Results 
 35
TER on Ctrl and IGF1R-/- keratinocytes
0 50 100 150
0
100
200
300
400
500 Ctrl
IGF1R-/-
Time (h)
O
h
m
 c
m
2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.8 Normal recruitment of  β-catenin and ZO-1 to cell-cell junctions in IGF-1R-/- 
keratinocytes 
To test whether the observed reduction in TER was due to impairment of intercellular junction 
formation, immunolocalization of the adherens junction component β-catenin was analyzed. 48 h 
after Ca2+ switch both control and IGF-1R-/- keratinocytes recruited β-catenin to sites of 
intercellular contacts, suggesting normal formation of adherens junctions. In addition, ZO-1, a key 
component of TJs, was normally recruited to sites of intercellular contacts 48 h after Ca2+ switch, 
a time point that marks the onset of TER formation, indicating TJ formation. Thus, IGF-1R does 
not seem to affect TJ function by regulating ZO-1 localization (Fig.20). 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Impaired in vitro barrier formation in IGF-1R-/- keratinocytes. (A) Schematic drawing of 
experimental setup. Keratinocytes were plated on porous filter inserts and electrical resistance of trans epithelia 
was measured using an automated Ohm meter. (B) Trans-epithelial resistance (TER) measurement of control and 
IGF-1R-/- keratinocytes. Values represent ± S.D. of 2 controls and 2 knockout cell line replicates.  
 
A B 
Figure 20: Adherens junction and tight junction formation in IGF-1R -/- keratinocytes (A) 
Immunofluorescence analysis of adherens junction (β-catenin) and tight junction (ZO-1) 
components. Keratinocytes were differentiated in high Ca2+ for the 48 h. Bar= 20 µm. 
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2.1.9 Impaired cldn-1 expression in differentiated IGF-1R-/- keratinocytes 
Cldn-1 is a critical component of the epidermal barrier (Furuse et al., 2002).  To assess whether 
alterations in cldn-1 levels are responsible for the observed impairment of barrier formation, WB 
analysis was conducted. Ca2+-induced differentiation caused increase in the levels of cldn-1 in 
control cells whilst in IGF-1R-/- cells there was no such increase to levels similar to control cells 
24 h after calcium. Even prolonged differentiation of IGF-1R-/- keratinocytes for 72 h did not 
induce increase in cldn-1 levels similar to control cells (Fig.21A,B), while the levels of ZO-1 were 
apparently unchanged (Fig.21A), indicating that IGF-1 signaling is regulating cldn-1 expression 
in cultured murine keratinocytes.  
To ask whether this regulation occurred on the level of transcription, RT-PCR analysis was 
performed to measure cldn-1 transcript levels. Semi-quantitative RT-PCR with cldn-1 specific 
primers was performed on 0 h and 48 h differentiated control and IGF-1R-/-cells. According to the 
band intensity on the gels at 48 h time points, there was clear reduction in transcript levels for 
knockout cells compared to those of controls. This data corresponds closely with that of TER 
analysis and provides further evidence that IGF-1 signaling is required for regulation of cldn-1 
expression (Fig.21D).   
β-catenin levels did not differ within 24 h following differentiation in control and knockout 
keratinocytes which complied with immunofluorescence results (Fig.21C).   
2.2.1 Preparation of dkoveinduc-/- mice to study vascular barrier property 
The observed deformities in epidermal barrier property for dkoepi-/- mice supported the idea that 
insulin/IGF-1 signaling are potential regulators of both the outside-in and inside-out epidermal 
barrier functions. Also in vitro, IGF-1 signaling regulates TJs in stratifying epithelia at least via 
controlling the expression of cldn-1 in differentiating keratinocytes. Hence to examine if 
insulin/IGF-1 signaling could similarly regulate the vascular barrier function mediated by 
endothelial cells, double knockout mice, termed vascular endothelial double knockout  (dkoveinduc-/- 
for IRve-/-/ IGF-1Rve-/-) having both vascular endothelial cell–specific deletion of the insulin 
receptor (VENIRKO) and IGF-1 receptor (VENIFARKO) were obtained using tamoxifen induced 
Cre-recombinase mediated deletion in adults, in which regulatory elements of Tie2 promoter 
drove Cre expression (Fig.22). 
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Figure 21: Impaired cldn-1 expression in differentiated IGF1R-/- keratinocytes. (A) Impairment in the cldn-1 
but not ΖΟ−1 levels in Ca2+ differentiated IGF1R-/- keratinocytes. Protein levels in 0, 24, 48 and 72 h 
differentiation time points are shown. (B) The quantification of the WB signal for cldn-1 shows the change in its 
expression within described time points. Signals for cldn-1 in each group were normalized to intensity of actin 
band signal. (C) No difference in β-catenin expression between control and IGF1R-/- keratinocytes during 24 h 
differentiation. (D) Lower cldn-1 transcript levels in 48 h differentiated IGF-1R-/- keratinocytes compared to 
control shown by RT-PCR in 30 and 40 amplification cycles. GAPDH is loading control.  
 
Si
gn
al
 in
te
ns
it
y 
(a
rb
it
ra
ry
 u
ni
ts
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0             24          48          72          0          24          48          72 
   IGF-1R -/-                                                  Ctrl 
 
cldn-1 
actin  
 
A 
C 
ZO-1 
 
       Ctrl                                   IGF-1R -/-                                               
 
D 
cldn-1 30X 
cldn-1 40X 
GAPDH 30X 
GAPDH 40X 
hours after Ca2+ switch 
hours after Ca2+ switch 
B 
0             1           2           24           0             1               2             24 
    Ctrl                                     IGF-1R -/- 
β-catenin 
 
actin 
 
21 kDa 
225 kDa 
90 kDa 
                                                                                                                                  Results 
 38
lox-p site 
Figure 23: Deletion efficiency for IR/IGF-1R genes in dkove-/- mice by PCR. (A) Mice no. 2, 5 and 6 
show complete deletion of IGF-1R gene. Mice 4, 7, 10 and 11 show less effective deletion of IGF-1R gene. 
Consistently high level of IR deletion in all mice carrying the Tie2-CreERT2 is detected. Mouse no. 3 does 
not carry the transgene. (B) The position of primers for deletion screening by PCR is illustrated 
schematically. 
 
 
Figure 22: Schematic illustration of the crossing and feeding to obtain dkoveinduc-/- mice.  
Deletion is achieved in adults via continuous feeding with tamoxifen for 5-6 weeks. 
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2.2.2 Variation in IGF-1R gene deletion after feeding with tamoxifen 
In order to obtain dkoveinduc-/- mice with deleted IR/IGF-1R genes, adult 4 weeks old mice carrying 
the Tie2-CreERT2 transgene were fed with a tamoxifen diet for 5-6 weeks following recommended 
procedure (Forde et al., 2002) after which the deletion efficiency for both IR and IGF-1R genes 
was determined by PCR primers spanning the floxed genomic region (Fig.23B) for each gene, 
using DNA template obtained from the heart as it provided a better estimation of the deletion 
efficiency compared to other DNA resources from the same mouse.  
Among dkoveinduc-/- mice fed for equal time points with tamoxifen diet, there was variation in the 
extent of the deletion for IGF-1R allele; on the other hand deletion for IR allele was consistently 
complete for all the mice examined in the experiments (Fig.23A).  
2.2.3 Viability and survival not affected in dkoveinduc-/- mice 
To investigate if deletion of both IR/IGF-1R genes in endothelial cells had any effect on the 
survival of dkoveinduc-/- mice, the viability of the mice was followed for 4 months after termination 
of tamoxifen feeding. dkoveinduc-/- mice survived into adulthood comparably similar to control 
littermates and did not show any lethality or abnormality in macroscopic parameters like weight 
and height (data not shown).  
Histological analysis by of different tissues in VEDKO mice by Hematoxylin and Eosin (H&E) 
staining showed no abnormality compared to control mice (Fig.24).    
2.2.4 Intact retinal vascular barrier integrity in the absence of IR/IGF-1R signaling 
To check if endothelial-specific deletion of IR/IGF-1R genes had any effect on retinal vascular 
barrier property, the dkoveinduc-/- mice were either perfused cardiacally or injected systemically with 
tracers of different molecular sizes i.e., 2000 kDa FITC-dextran or 443 Daltons amine reactive 
biotin (see 2-1-2) respectively.  
Retina wholemount samples from all dextran and biotin infused mice were analysed to visualize 
the primary plexus, inner deeper plexus and outer deeper plexus in both dkoveinduc-/- and control 
mice. According to the vascular segregation pattern visualized by FITC-dextran in different 
vascular levels of retina, there was no obvious difference in the branching and vascular 
morphology or density in all studied retinas for control and knockout groups (Fig.25B). High 
vascular competency to retain relatively bigger dextran tracer in control and knockout groups was 
indicative of apparently intact vascular barrier (Fig.25B). Biotin detection in retinal paraffin 
sections allowed visualizing the extensive leakage in choroidal blood vessels (Fig.25C) that are 
porous vessels with vascular fenestrations (Bernstein and Hollenberg, 1965). Vessels of the 
primary plexus showed certain amounts of leakiness in both control and dkoveinduc-/- mice which 
should not be interpreted as abnormal and could be accounted for by the fact that the vasculature 
in these layer form extensive ramification and branching into deeper retina to form the inner 
plexuses which is erroneously reflected as leaky.  
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On the other hand according to normal histological staining (Fig.24A) and tracer perfusion results 
(Fig.25B, C) there was no indication of pathological oxygen-induced retinopathy (OIR) 
phenotype, a vasoproliferative  condition characterized by the growth of tortuous and leaky 
vessels that form tuft-like structures towards the vitreous (Chen and Smith, 2007).  The vascular 
retentiveness to the smaller 443 Daltons tracer in the retinal vasculature of the studied mice led to 
the conclusion that ablation of endothelial IR/IGF-1R genes does not cause any alteration in 
retinal vascular barrier function of adult mice (Fig.25C), although the full deletion of both genes 
in dkoveinduc-/- could not be fully certified using other techniques such as RT-PCR, 
immunofluorescence or WB.   
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Figure 24: H&E staining of different tissues in dkoveinduc-/- and control mice. (A) Retina; ganglion cell layer 
(GCL), inner nuclear layer (INL), outer nuclear layer (ONL) inner plexiform and outer plexiform layers (IPL and 
OPL). PE is pigmented epithelium. (B) lung, (C) skin, (D) aorta. Bar= 20 µm. 
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Figure 25: Normal retinal vascular barrier integrity in dkoveinduc-/- mice. (A) Panel depicts various types of 
vessels in the longitudinal retinal section. (B) Normal retention of 2000 kDa FITC-dextran in three different 
retinal vessel types in dkoveinduc-/- and control mice. (C) Normal retention of biotin shown in flatmounted retinal 
quarter and retinal paraffin sections. Different types of retinal vessels are marked. Bar=100 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.5 Isolation of primary lung endothelial cells 
As vascular permeability in the CNS is controlled by the biochemical properties of  the 
neurovascular unit (NVU) (Cardoso et al., 2010); therefore in dkoveinduc-/- mice, any disturbance in 
permeability sealing function of endothelial cells could be disguised by compensatory functions of 
the cells in the NVU conformation. 
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Figure 26: Monolayer growth of freshly isolated primary lung endothelial cells. Endothelial cells 
were isolated from lung tissue homogenates using PECAM-1 conjugated beads and grown on plastic 
dishes. Bar=10 µm. 
Subsequently to understand the role of insulin/IGF-1 signaling in the endothelial barrier function 
via TER measurements as was described previously for the keratinocytes, primary endothelial 
cells were isolated from the lungs of 3 weeks old adult mice (Fig.26) using PECAM-1 antibody 
conjugated beads to obtain IRendo fl/fl/ IGF-1Rendo fl/fl endothelial cells in an effort to convert these 
cells to dko cells using a TAT-Cre recombinase (Peitz et al., 2002) in vitro.  
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.6 Generation of double knockout IR-/- / IGF-1R-/- primary endothelial cells  
In order to obtain dko endothelial cells, primary endothelial cells in passage 1 were treated with 
either 2µm 4-OHT or different concentrations of a purified cell permeable Cre-recombinase 
(HTNC) protein which can potently ablate floxed genes in cultured cells (Peitz et al., 2002). 
In transgenic Tie2-CreERT2 cells, translocalization of CreERT2 protein from cytoplasm to nucleus 
requires binding of tamoxifen (TA) or its derivative 4-hydroxytamoxifen (4-OHT) to ERT2 
domain which does not tend to bind to endogenous estrogens. This binding will carry the 
recombinase from cytoplasm into nucleus which finally drives gene deletion (Feil et al., 1996).  
Based on PCR results, even prolonged 4-OHT treatment for 4 days did not cause any deletion of 
the target genes (Fig.27A); whereas, both IR and IGF-1R genes were effectively excised by 
overnight HTNC treatment. As a result while IR gene showed highly efficient deletion already at 
625nM concentrations of HTNC, IGF-1R gene required 5µm concentration of the recombinase to 
show complete deletion (Fig.27A). These observations exhibited a nice overlap with deletion 
efficiency for both genes in vivo, where excision was induced by tamoxifen inducible Cre 
(Fig.23A) and IGF-1R gene showed variable levels of deletion in different mice while IR gene 
was effectively deleted in all mice.  
The cellular toxicity induced by applying micromolar concentrations of HTNC necessitated 
intermission of one week and further passaging of cultured cells to achieve recovery and 
propagation. Unfortunately endothelial cells in passage 2 showed restoration of the floxed IGF-1R 
allele which obstructed further usage of the cells for the planed experiments indicating that not all 
HTNC treated cells were completely deleted for IGF-1R gene and growth advantage of such cells 
caused outnumbering effect over IGF-1R-/- cells (Fig.27B). 
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Figure 27: PCR showing deletion of IR and IGF-1R genes in cultured endothelial cells treated 
with HTNC and 4-OHT. (A) IGF-1R gene requires higher levels of HTNC for proper deletion 
compared to IR gene. Lack of gene deletion in cells treated for the indicated time points with 4-OHT. 
(B) Restoration of the floxed IGF-1R allele in HTNC treated dko endothelial cells in passage 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3 Generating a conditional knockout mouse for PAR-3 gene  
Double epidermal IR/IGF-1R gene inactivation highly implicated alteration of tight junction 
function both in vivo and in vitro. Therefore, mouse PAR-3 gene was targeted as a downstream 
candidate for regulation via IGF-1 signaling in the mouse epidermis using homologous 
recombination to replace the PAR-3 genomic DNA sequence with a lox-p flanked fragment of the 
same region. 
2.3.1 Detection of PAR-3 transcripts in primary mouse keratinocytes by RT-PCR 
Multiple spliced variants of PAR-3 are found in mammalian cell lines and tissues (Gao et al., 
2002). All of the known splice variants were shown to arise from a single start codon located in 
the CR1 domain of the protein (Fig.28B) and a knockout mouse model was generated based on 
the assumption of a unique start codon (Hirose et al., 2006), while later a novel start codon was 
identified by Duncan and colleagues (2005), as they showed the existence of transcripts in mouse 
oocyte arising from a second start codon located in exon number 4. Therefore, the expression of 
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Figure 28: Detection of various start and stop codon sites for PAR-3 transcripts in cultured mouse 
keratinocytes by RT-PCR. (A) The relative position of primers on the genome used for RT-PCR analysis. 
The exons and introns are not drawn to scale. Exons are drawn as solid vertical bars. (B) Protein domain 
organization of various translated PAR-3 transcripts and the respective site of the primers for RT-PCR with 
their number is shown. (C) RT-PCR products of PAR-3 using assigned primers. All start and stop sites are 
amplified. Product size; 1-2: 590 bps, 4-5: 747 bps, 4-6: 495 bps, 7-8: 521 bps, 3-2: 198 bps. 
 
all possible transcripts in mouse cultured keratinocytes was evaluated by RT-PCR initially using 
primers specific for the 5´UTR region of the transcript derived from exon 4, exon 1 and 3´UTR 
site specific primers to identify all possible transcripts (Fig.28). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Using different primer sets, all previously known start and stop codon sequences were amplified. 
A faint band with expected size of 198 bp was amplified using primers 9 and 10 suggesting the 
expression of the novel transcript with second ATG utilization in cultured keratinocytes (Fig 
28C). According to RT-PCR data, the second start site provided lesser abundance compared to the 
first start site, implying limited use of this transcript by translational complex in keratinocytes. 
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Figure 29: Diagram of PAR-3 genomic organization, targeting strategy and PAR-3exon4 flox targeting 
construct. (A) Exons are shown as vertical bars with relatively close ratio to their corresponding genomic 
size. Two start sites are marked with red arrows. (B) Respective position of the restriction sites, selection 
cassettes, probes for southern blot screening (pink and blue bars) and lox-p sites (black triangles) are 
illustrated. (C) PAR-3exon4flox plasmid used for homologous recombination in embryonic stem cells. 
Restriction sites, FRT and lox-P sites, homology arms and the vector backbone fragments are shown. (D) 
Agarose gel showing the linear PAR-3exon4 flox vector (lane-1, 16611 bps) digested with NotI next to a non-
digested supercoiled construct (lane-2). 
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Figure 30: PCR to identify ES cell clones with correctly targeted PAR-3exon4. (A) Picture 
showing the orientation of the primers used for each PCR and their respective product size. (B) 
Marked with asterisks, clones H12 and H1 show bands of expected sizes for both left and right 
PCRs. Clone D12 was not a correctly targeted clone according to left arm PCR. 
 
2.3.2 Generation of a targeting plasmid for mouse PAR-3 gene  
Mouse par3 gene consists of  25 known exons and as mentioned before two transcription start 
sites have been characterized for the gene, the first one in exon1 and second one in exon4 
(Fig.29A). We planned to produce a conditional knockout mouse which will cause timed and/or 
tissue specific deletion of the exon4 which allows (i) production of a truncated protein via a 
premature stop codon due to frame shift in exon5 provided that the first start codon is used (ii) 
removal of the second start codon in exon4 leading to no production of PAR3 mRNA transcripts 
given the usage of the second start codon (Fig.29B). The resulting targeting construct was ~ 16.6 
kb and was linearized on NotI site just before short homology arm. Linearized construct was used 
for electroporating the ES cells (Fig.29C and Fig.29D). 
2.3.3 Production of PAR-3exon4 flox/+ embryonic stem cells 
PCR and Southern blot analysis using site specific primers and probes were used to identify the 
correctly targeted ES cell clones for blastocyst injection. PCR using primers spanning the NeoR 
cassette, 5´ FRT and lox-p sites and 5´upstream left arm of homology with product size of 4.3 kb 
and primers to amplify 3´ lox-p site and 3´downstream right homology arm with product size of 
5.6 kb, showed two ES clones with correctly targeted Par3 allele. The clones H1 and H12 were 
identified as promising clones for generating chimeric males and were further validated for 
correct recombination via southern blotting (Fig.30).  
Southern blot using the probes for left and right homology arms using KpnI and XbaI restriction 
enzymes validated PCR results for two selected clones, H12 and H1. A blot with probe for NeoR 
site further supported the single integration event of the plasmid arms in homologous genomic site 
as both the mentioned clones were showing a single band with expected size of approximately 9 
kb for KpnI digest (Fig.31).  
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Figure 31: Southern blot confirmation of correct Par3exon4 targeting in ES cell clones. 
(A) Radiolabeled probe to distinguish wt (7.4 kb) and floxed (9.5 kb) alleles for the left 
arm of homology using KpnI digest. (B) Probe to distinguish wt (8 kb) and floxed (6.8 kb) 
alleles for the right arm of homology using XbaI digest. (C) NeoR-specific probe to detect 
single integration of the targeting fragment using KpnI digest. 
 
Figure 32:  Deletion-competent lox-p sites in ES cell clones selected for generating knockout PAR-3 
mouse. PCR using primers in 5´and 3´flanking regions of left and right lox-p sites shows deletion band in both 
selected clones only in the presence of HTNC. 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.4 Production of PAR-3exon4 -/+ embryonic stem cells 
In order to functionally scrutinize the ability of the lox-p sites in mediating the excision of the 
exon 4 in selected clones at the presence of the Cre recombinase, the cell permeable Cre 
recombinase (HTNC) was applied to test cultured ES cells. Subsequently, a deletion PCR was 
performed on genomic DNA following Cre treatment to distinguish between wt (1.9 kb), floxed (4 
kb) and deleted (1.5 kb) alleles (Fig.32). Both selected clones provided a deletion band of the 
expected size below wild type band upon HTNC treatment but floxed allele was not amplified, 
may be due to preference of Taq-polymerase in amplifying shorter fragments while using the 
same primers. 
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Figure 33:  Chimeric PAR-3exon4 flox/+ males obtained from injecting the selected ES cells. 
Chimeric males are distinguished by typical patchy coat color and were crossed with wt C57/Black6 
females for germline transmission. 
2.3.5 Generation of chimeric mPAR-3exon4 flox/+ males 
The selected clones were injected into 60 hosting CB-20 blastocysts and were implanted to 
psuedo-pregnant foster-mothers to obtain chimeric offspring. In total 11 males were born (Fig.33) 
of which 5 had chimeric skin patch ratio of above 50% and were used in crossing with 
C57/Black6 females to obtain transmitted floxed allele in the offspring which required to be 
checked by both PCR and Southern blot. In sum, 1000 pups were born and analyzed by PCR to 
detect transmission of the floxed allele to the progeny and even 2 mice with black coat color were 
born; all of which were wild type. A better alternative is to obtain new targeted clones using low 
passage ES cells for blastocyst injection to increase the chance of having highly chimeric males. 
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3 Discussion 
The mammalian vascular barrier mainly regulates the one-way movement of blood cells and 
molecules across the vascular lumen. On the other hand epidermis is a largely two-way barrier; an 
organ with lifelong self-renewal capacity, providing a stratified epithelium that functions as a 
barrier to separate the organism from the environment and external pathological factors and protect 
it against dehydration. Studies on animal models of skin diseases and inherited skin disorders in 
humans generally support the notion that barrier function depends on a differentiation process that 
on the one hand results in coordinated protein and lipid deposition in stratum corneum and on the 
other the formation of functional tight junctions in the granular layer of the epidermis (Tsuruta et 
al., 2002). Vascular barrier formation is dependent on the formation of adjacently positioned, 
adhesive barrier units, the endothelial cells that are generally sealed in their intercellular junctions 
by adhesive AJ and TJ complexes (Dejana, 2004). 
In this thesis we addressed the role of cell autonomous insulin/IGF-1 signaling in skin barrier 
formation and function and in endothelial barrier function. Epidermal specific inactivation of both 
the insulin receptor (IR) and IGF-1 receptor (dkoepi-/-) resulted in perinatal death (Stachelscheid et 
al., 2008). Here we show that dkoepi-/- have increased transepidermal water loss when compared to 
control mice, resulting in severe dehydration and early neonatal lethality. Defective barrier 
formation was associated with a strong delay in functional outside-in barrier formation during 
embryogenesis as assessed by toluidine blue assays, altered appearance of cornified envelopes as 
well as abnormal ceramide content of intercorneocyte lipids in the stratum corneum. In addition, 
preliminary results suggest that processing of filaggrin, an important barrier protein, might be 
perturbed. In contrast, our initial analysis with subcutaneously injected tracer did not reveal any 
obvious defects in tight junctions although this requires more detailed analysis. In line with these 
findings, global gene expression data (Stachelscheid and Niessen, unpublished results) revealed 
major changes in expression of a range of proteins involved in regulating both the structural as well 
as the epidermal immune barrier (Table-1).  
In contrast no obvious defects in vascular integrity could be observed when insulin receptor and 
IGF-1R receptor were deleted in adult vascular endothelial cells using an inducible Tie2-Cre 
system. This could either be due to the fact that endothelial insulin/IGF-1 signaling does not 
regulate vascular function under steady state conditions and that they only play a role in restoring 
vascular function after this has been disturbed, e.g. by induction of hypoxia or wounding. On the 
other hand, the results showed that inactivation of especially IGF-1R gene was highly variable 
ranging from over 90% of deletion to less than 10% and may have therefore been insufficient to 
observe a functional difference. In conclusion, the work presented in this thesis shows that 
Insulin/IGF-1 signaling are crucial cell autonomous regulators of epidermal barrier formation and 
function in the skin. 
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3.1 Insulin/IGF-1 signaling in epidermal barrier morphogenesis 
The results presented in thesis showed that absence of insulin and IGF-1 signaling resulted in 
prenatal death due to defective epidermal water barrier function, thereby introducing insulin/IGF-1 
signaling as key regulator of mouse EPB formation. The prenatal lethality observed in dkoepi-/- mice 
is similar to several other mouse models with epidermis-specific inactivation of enzymes involved 
in protein and lipid modification such as CAP-1/Prss8, Alox-12b, β-glucocerebrosidase, 
glucosyltransferase (Ugcg) and stearoyl-Coenzyme A desaturase 1 (SCD-1) (Leyvraz et al., 2005; 
Epp et al., 2007; Hanely et al., 1997; Jennemann et al., 2007; Binczek et al., 2007). Basically the 
observed delay of epidermal barrier formation during embryogenesis in dkoepi-/- mice is a hallmark 
of most of the aforementioned knockout mice. The late recovery in barrier acquisition in 
exemplified mutant mice indicates that compensatory mechanisms are activated in the course of 
morphogenesis in order to fulfill establishing a proper barrier before transition from humid in utero 
environment to dry desiccating conditions after birth. We observed apparent success of such 
compensatory efforts in the skin of the P0 dkoepi-/- mice by almost complete exclusion of LY and 
toluidine blue (Fig.34).    
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterization of the genes responsible for barrier recovery in our dkoepi-/- mice requires analysis 
of several candidate genes which have been identified to be important in the proper establishment 
of the epidermal barrier. The late recovery in epidermal outside-in barrier of dkoepi-/-mice compared 
to control embryos, as shown by partial toluidine blue exclusion in E18.5 back skin, implicates 
upregulation of transcription factors between E16 until birth in these mice. These proteins are 
probably responsible for over production of protein or lipid components of the stratum corneum. 
The transcription factors such as Kruppel-like factor 4 (Klf4), Grainy head like-3 and AP-2 gamma 
Figure 34: Delayed outside-in barrier formation in dkoepi-/- embryos: Control mice show barrier 
acquisition in a constant rate between E16 and E18.5. Dkoepi-/- embryos exhibit delayed initiation, 
much reduced rate of barrier acquisition and late recovery of barrier function around embryonic 
stage E19. 
Embryonic development stage 
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(Segre et al., 1999; Ting et al., 2005; Guttormsen et al., 2008) are required for proper EPB 
acquisition and would be interesting to analyze their expression in dkoepi-/- epidermis.  
In support of such compensatory efforts, the transcript levels for several structural proteins with 
late recruitment to SC belonging to Sprr, LCE and keratin protein families were found to be 
upregulated (Table-1).  
To analyze the SC components with known essential roles in EPB formation, we analyzed the free 
extractable ceramides and corneocytes from dkoepi-/-. Significant deviation in the levels of long 
chain ceramides (Cer(C16/18 NS) and Cer(C24/26 NS)) was observed compared to control mice. 
This finding was invaluable as insulin/IGF-1 signaling, with known essential roles in mammalian 
development, was demonstrated in our work as central regulator of EPB formation via at least in 
part, regulating lipid metabolism in developing epidermis. The microarray data showed an overlap 
with altered lipid metabolism, as several key enzymes in ceramide synthesis and modification were 
affected (Table-1). One striking finding on ceramide profile of dkoepi-/- mice was the high level of 
accumulated glucosylceramides (GlcCers). GlcCers are major precursors for ceramide production 
in the in CE (Doering et al., 2002), therefore are considered as probarrier lipids. The accumulated 
GlcCers in dkoepi-/- mice would possibly be outlined in two ways (i) GlcCers are produced normally 
but could not be converted into ceramides, (ii) GlcCers are overproduced by keratinocytes as a 
compensatory reaction to increase ceramide production. Based on non-confirmed microarray data it 
appears that the second explanation is reasonable, as the levels of the GlcCer converting enzyme 
(Ugcg) was higher in dkoepi-/- epidermis.  
Insightful analysis of the production and conversion of various ceramide molecules in dkoepi-/- mice 
demands analyzing the lipid content and mRNA transcript levels of key ceramide metabolizing 
enzymes (Table-1) of SC in late embryonic stage, e.g. E18. This gestational time point represents 
the time point during which GlcCers decline and their respective ceramides rise. This is reflected 
by increase in the levels of Cer(NS) and Cer(NP) by 25% and 440% respectively compared with 
earlier gestational time points which occurs parallel to decrease in the levels of their corresponding 
GlcCers indicating conversion of GlcCers to their respective ceramide types in the epidermis 
(Doering et al., 2002). Regardless of their critical role in epidermal water barrier development, we 
did no analyze the protein bound ceramides of the dkoepi-/- mice. The gradual rise in the levels of 
ceramide types is also reported for protein bound ceramides of the epidermis (Doering et al., 2002) 
and we expect alteration in such corneocyte bound ceramids in dkoepi-/- mice as well. The analysis 
of these ceramide types will be conducted and requires release of ester linked epidermal lipids by 
alkaline hydrolysis and TLC analysis (Doering et al., 2002).  
Despite the delay seen in barrier acquisition for dkoepi-/- mice, the late recovery followed a normal 
pattern reported in barrier development (Hardman et al., 1998). Normal expression of terminal 
differentiation markers such as involucrin, a protein marker of early differentiation normally 
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expressed in the upper spinous layers (Eckert et al., 1993), and loricrin, a marker of late 
differentiation (Mehrel et al., 1990) indicated normal development of upper spinous and granular 
layers of epidermis in P0 dkoepi-/-mice. Irrespective of their apparently normal epidermal 
differentiation, corneocytes from dkoepi-/- mice and adult IGF-1Repi-/- mice, showed alteration in 
shape and interestingly FLG processing appeared to be impaired in dkoepi-/- mice.  
Proper CE assembly is essential in skin barrier development, as transglutaminase-1 deficient mice 
that lack confirmed envelopes, suffer from water loss, resulting in neonatal lethality (Matsuki et al., 
1998). Alterations in corneocyte shape and resistance have also been described in various mouse 
models with defective skin barrier formation, ranging from irregularly shaped corneocytes in 
Prss8epid-/- mice to fragile corneocytes envelopes in Alox-12epid-/- mice (Leyvarez et al., 2005;  Epp 
et al., 2007). Corneocyte phenotype in dkoepi-/- mice resembled more that of Prss8epid-/- deficient 
mic. CAP1/Prss8 activates ENaC in epithelial cells and is known to be responsible for ENaC-
mediated sodium current across the cells (Planès et al., 2010). Prss8epid-/- mice demonstrated 
impaired epidermal water barrier function, accompanied with defective FLG processing, reduced 
levels of protein bound ceramides and abnormality in corneocyte and outside-in barrier. 
Our dkoepi-/- mice share some skin abnormality features with Prss8epi-/- mice including defective 
outward and perhaps a defective inward barrier, morphological change of corneocytes and FLG 
processing. However, the epidermis in Prss8epi-/- mice was much thicker than the dkoepi-/- mice; 
presenting thin epidermis with low stratification as a factor which could account for less efficient 
barrier function in dkoepi-/- mice.  
In light of the fact that filaggrin monomers are capable of binding and collapsing keratin filaments 
in the corneocyte (Lynley and Dale, 1983); therefore, defective monomeric FLG production could 
serve as one potential explanation for the abnormal corneocyte phenotype of dkoepi-/- mice. An 
informative assay to demonstrate the integrity of the corneocytes in dkoepi-/- mice is ultrasound 
treatment and assessment of their resistance by microscopic analysis. Nevertheless it appears that 
proper deposition of the lipid matrix in CE and FLG processing are coupled and mutually depend 
on each other. For example, mice with a targeted disruption of Alox-12b, an enzyme involved in 
fatty acid modification, showed a disturbed fatty acid composition of epidermal ceramides leading 
to neonatal death caused by water loss which was accompanied by absence of FLG (Epp et al., 
2007). On the other hand, epidermal inactivation of the transmembrane serine protease, 
Matriptase/MT-SP1, which is known to process profilaggrin and produce FLG; lead to FLG loss 
together with the perturbation of lipid matrix formation. Therefore the judgment on whether 
impaired lipid production in dkoepi-/- is merely due to loss of insulin/IGF-1 signaling and not FGL 
production is impossible at this point.  
An interesting finding with relevance to the small reduction in FLG production in dkoepi-/- mice 
which needs further validation, was almost 3 fold upregulation of a serine protease inhibitor, 
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Serpinb2 and downregulation of Tmprss4 (a family member of CAP-1/Prss8 protein). The family 
of serine protease inhibitors (SERPINs) genes comprises approximately 40 members. Serpins 
inhibit their target proteases by covalent binding leading to conformational change of the protease 
and thus abrogation of the function. Some previous studies on host-pathogen interactions have 
demonstrated that serpins are most likely responsible for protecting the host from bacterial 
proteases (Kaiserman et al., 2006). However new insights have revealed serpins to contribute in the 
reinforcement of the poorly developed epidermal cornified layer (Geng et al., 2006; Sevilla et al., 
2007). Serpinb2 might potentially contribute to vitalizing the epidermal barrier of our dkoepi-/- mice 
by reducing desquamation rate which is facilitated by the degradation of corneodesmosome 
proteins (Guerrin et al.,1998; Simon et al., 2001). On the other hand proteases involved in 
profilaggrin processing might be inhibited by Serpin activation in the dkoepi-/- mice. Tmprss4 was 
recently shown to induce invasion and epithelial–mesenchymal transition (Kim et al., 2010). Low 
Tmprss4 transcript levels in dkoepi-/- mice as shown by microarray data requires further validation 
by more quantitative techniques and would possibly shed new insights on the identification of new 
protease engaging profilaggrin processing.  
The abnormal corneocyte phenotype in the IGF-1Repi-/- mice implies perturbation in protein 
components of CE. Therefore it is planned to investigate if adult IGF-1Repi-/- mice show reduced 
amounts of FLG similar to P0 mice. The results of this experiment might enable us to determine if 
FLG processing is regulated by IGF-1 signaling. 
Caspase-14 was characterized as a protease involved in filaggrin processing; therefore its 
expression and cleavage to release functional isoforms in dkoepi-/- epidermis was investigated. We 
looked for any regulatory effect of insulin/IGF-1R signaling on casp-14 expression and to 
investigate if reduced FLG in dkoepi-/- epidermis was due to reduction in active casp-14 levels. 
Casp-14 deficient mice are sensitive to UV irradiation and represent abnormal degradation of 
FLG to smaller 15-20 kDa fragments (Denecker et al., 2007). The normal levels of non-active and 
active casp-14 in the epidermis of dkoepi-/- mice suggests that insulin/IGF-1 signaling does not 
regulate the expression of casp-14 in the epidermis and probably this protease is not responsible 
for the observed impairment of FLG processing in dkoepi-/- mice.  
In order to investigate proper epidermal inside-out barrier, intraderaml biotin injection and cldn-1 
immunolocalization were performed. There was indication for biotin diffusion in some areas of 
the epidermis above the granular layer to SC which was not conclusive and needs repetition of the 
experiment. In addition, TER assays did not show consistent differences between control and 
IGF-1R keratinocytes. On the other hand, normal cldn-1 signal was observed at cell-cell contacts 
in all suprabasal layers of the epidemris, indicating relatively normal assembly of TJs.  
Cldn-1 WB also showed no difference in epidermal expression between experimental and control 
samples. Based on observed accelerated epidermal water loss and apparently normal epidermal 
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TJs, it is not possible in this point to make firm conclusions on integrity of TJs in dkoepi-/- 
epidermis. However, abrogation of cldn-1 expression and inconsistently lower TER values seen in 
differentiating IGF-1R-/- keratinocytes implies regulation of TJs by IGF-1R mediated signaling in 
stratifying epithelia. In particular, the regulation of cldn-1 by IGF-1 signaling highlights 
requirement for in depth analysis of the downstream pathways.   
 
UniGene                                                   Gene name                                                        Fold change                   Affymetrix Probe Set ID 
  
Cornified envelope components 
Sprr2f                                                     small proline-rich protein 2F                                   203.84                            1449833_at 
Sprr2i                                                     small proline-rich protein 2I                                    165.72                            1422963_at 
Sprr2d                                                    small proline-rich protein 2D                                   14.09                              1420771_at 
Sprr1b                                                    small proline-rich protein 1B                                   11.54                              1422672_at 
Sprr2k                                                    small proline-rich protein 2K                                   10.21                              1422425_at 
Sprr2h                                                    small proline-rich protein 2H                                   5.87                                1422240_s_at 
Lce3b                                                     late cornified envelope 3B                                       157.42                            1456001_at 
Krt2-6a                                                   keratin complex 2, basic, gene 6a                           18.96                               1422783_a_at 
Krt6a                                                      keratin 6A                                                                20.49                              1427700_x_at 
Krt1-16                                                   keratin complex 1, acidic, gene 16                          13.71                             1448932_at 
Krt2-6a                                                   keratin complex 2, basic, gene 6a                            9.86                               1422784_at 
Krt2-6b                                                   keratin complex 2, basic, gene 6b                            8.2                                 1422588_at 
Krt36                                                      keratin 36                                                                  2.48                               1427751_a_at 
Krt17                                                      keratin 17                                                                  1.6                                 1423227_at 
 
Ceramide metabolism   
Ugcg                                                     UDP-glucose ceramide glucosyltransferase     2.42, 2.31, 1.98    1421269_at, 1421268_at, 1435133_at                                        
Psap                                               prosaposin                                                  -1.55,-1.69                     1421813_a_at, 1415687_a_at                                                                          
Acer3                                                    alkaline ceramidase 3                                              -1.51                                1438435_at 
Cerk                                                      ceramide kinase                                                       -1.76                                1434034_at 
Scd1                                                      stearoyl-Coenzyme A desaturase 1                         -7.78                                1415964_at 
Alox12e                                                arachidonate lipoxygenase, epidermal                     -2.16                                1426039_a_at 
Alox5ap                                                arachidonate 5-lipoxygenase activating protein      -2.28                                1452016_at 
Alox12                                                  arachidonate 12-lipoxygenase                                 -2.69                                1422699_at 
 
Epithelial host defense proteins 
Defb3                                                   defensin beta 3                                                        14070.49                           1421806_at 
Defb1                                                   defensin beta 1                                                           2.71                                1419491_at 
Ptgs2                                                    prostaglandin-endoperoxide synthase 2                 19.54, 8.89                         1417262_at, 1417263_at 
Ptges or mPGES-1                               prostaglandin E synthase                                        3.62, 2.54                          1439747_at, 1449449_at 
 
Corneosome stability  
Serpinb2                                             serine (or cysteine) proteinase inhibitor, clade B       2.95                                 1419082_at 
Ctss                                                     cathepsin S                                                                -3.29                                 1448591_at 
Tmprss4                                              transmembrane protease, serine 4                             -1.61                                 1426302_at 
 
Table 1: List of genes derived from the gene expression analysis with relevance to epidermal 
differentiation and function 
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3.2 Insulin/IGF1 signaling in vascular barrier function 
Largely normal retinal vascular barrier integrity in dkoveinduc-/- mice indicated that insulin/IGF-1 
signaling may not play a role in vascular barrier function under steady state vascular conditions. 
However variable efficiency of the Cre mediated deletion for IGF-1R gene in adult dkoveinduc-/- mice 
prevented conclusive demonstration if insulin/IGF-1 signaling is dispensable for the maintenance 
of retinal vascular integrity. As knockout mice carrying a constitutively expressed Tie2Cre line 
provided a better deletion outcome for both genes (Kondo et al., 2003), such transgenic mouse line 
which is described to show deletion of the floxed genes exclusively in the endothelial cells would 
be the line of choice to cross with the IR/IGF1Rflox/flox mice to obtain dkoveinduc-/- mice (Pandelakis 
et al., 2001). If the mice obtained from these crossings are viable an interesting analysis is to 
evaluate the vascular barrier integrity in challenging hypoxia-induced conditions of oxygen 
induced retinopathy (OIR) assay.  This assay is conducted exclusively on newborn mice and allows 
understanding the specific role of insulin/IGF1 receptors in either oxygen-induced vasoobliteration 
phase or vascular leakage promoting neovascularization phase (Smith et al., 1994). 
The angiogenic stimuli driving the vascular reestablishment in the wounded skin are mediated by 
hypoxia induction in the wound site which is very similar to hypoxia conditions of OIR (Wattel et 
al., 1990). Thus another highly relevant model to understand the role of insulin/IGF-1 signaling in 
angiogenesis and vascular barrier function is analysing the skin wound healing response in the 
dkoveinduc-/- mice which could provide information about the role of vascular IGF-1 signaling in non-
healing diabetic wounds. This experiment is at the moment ongoing using dkoveinduc-/- mice. A 
common microvascular-specific ocular disease in diabetes with late onset, directly related to 
globally imbalanced IR/IGF-1R signaling is diabetic retinopathy. Understanding the role of these 
signaling pathways would potentially contribute to the development of appropriate treatments set to 
adjust the activity levels of both pathways to normality.   
3.3 Setbacks and prospects of the Par3exon4flox mouse project 
Although in this project we did not obtain mice with germline transmission of the targeted Par-3 
allele, but two chimeric males successfully generated two pups with a distinct black coat color. 
This indicated fertilization of the female oocytes with sperms derived from injected ES cells. 
Southern blot and PCR analyses showed that both mice carried the wild type allele. Setting 
extensive crossings with high number of wild type females for the two promising chimeric males 
did not result in germline transmission. This indicated the low contribution of the injected ES cells 
in the blastocysts to spermatogenesis procedure in the chimeric fathers. Currently another 
transfection attempt with the targeting construct has been undertaken using ES cells with low 
passage and high germline transmission potential.  
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With respect to the crucial role described for Par-3 protein in cell polarity determination and the 
formation and function of TJs (Hirose et al., 2002), following generation of the Par3exon4flox mouse, 
crossings between Par3exon4flox and either K14-Cre or Tie2-Cre mice will be performed. Par-3ve-/- 
and Par-3epi-/- knockout mouse models will enable us to answer important questions on the role of 
Par-3 in epidermal morphogenesis and barrier acquisition in epidermis and the vascular system. 
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4 Materials and Methods 
4.1 Mice 
4.1.1 Insulin receptor and IGF-1 receptor floxed mice 
The generation and genotyping of the insulin receptor floxed, IGF-1 receptor floxed and the K14-
Cre mice and deletion screening by PCR have been described (Bruning et al., 1998; Hafner et al., 
2004).  
4.1.2 Generation of PAR-3exon4 flox/+ mouse  
The Par-3 targeting construct was prepared by PCR amplification of the left 3.7 kb and right 5 kb 
flanking regions of PAR-3exon4 gene which after subcloning were inserted into their respective 
restriction sites in pEasyflox plasmid as final targeting construct. Briefly, exon 4 and its flanking 
5´and 3´ region (637 bps PCR product) was inserted into 5´-AscI/MfeI-3´ sites, the short arm was 
inserted into 5´-NotI/AvrII-3´ sites before the first lox-p and Neo site and the long arm was 
inserted between the second lox-p site and Tymidine Kinase selection cassette in 5´-XhoI/PmeI-3´ 
restriction sites. The Par-3 targeting construct was linearized by NotI digestion, yielding a 16611 
bps plasmid. The NotI-linearized plasmid was subsequently used for electroporation in cultured 
embryonic stems (ES) cells 
Gene targeting was performed in 129/C57Black 6 hybrid ES line, V6.5. For transfection, 1x107 
ES cells were transfected with 50 µg DNA. Approximately 9 days after transfection, G418-
resistant, Ganciclovir-sensitive colonies were picked and expanded on 96-well tissue culture 
dishes. Genomic DNA was extracted from each clone and analysed by Southern blot and PCR 
analysis. The selected ES cell clones were subsequently expanded and transfected in vitro with 
Cre recombinase (HTNC) to check the efficiency of the lox-P sites in mediating neo-exon4 
deletion by PCR using sense “for-sapar3-1” and anti-sense “3-floxedpar3 in LA”primers to 
distinguish between wild type (2 kb) and deleted (1470 bps) alleles. Recovery, microinjection and 
transfer of 3.5 day p.c. embryos were performed according to standard procedures. Chimeric 
animals (50-65% chimerism based on coat color) were bred with female C57Black 6 background. 
The list of all the primers for genotype determination as well as deletion and long-range cloning 
PCRs are provided in Table-2. 
4.1.3 Feeding with tamoxifen diet  
Adult (three weeks-old mice), the Tie2CreERT2/+ IR/IGF-1Rfl/fl mice and the Tie2CreERT2+/+ IR/IGF-
1Rfl/fl littermates, were fed for 5-6 weeks with free access to a chow containing 0.4 mg tamoxifen 
per kg of food (Forde et al., 2002).  
4.2 Molecular DNA techniques 
4.2.1 DNA Ligation 
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For ligation of specific inserts into plasmids, the T4 ligase and its corresponding buffer 
(Fermentas) were used. The ligation was done overnight at 16°C. Insert DNA and vector DNA 
were ligated in a relation of 3:1. 
4.2.2 DNA Digestion and de-phosphorylation of DNA fragments 
All DNA modifying enzymes (i.e. restriction enzymes, T4 DNA ligase, calf intestinal phosphatase 
(CIP), Klenow fragment polymerase) were purchased from New England Biolabs and used 
according to the manufacturer’s protocol. 
4.2.3 Recombinant DNA techniques 
The following standard recombinant DNA techniques were performed as described in Sambrook 
and colleagues (1989), or according to the manufacturer’s instructions: restriction digestion, T4 
DNA ligation, dephosphorylation of DNA fragments, agarose gel electrophoresis and elution of 
DNA fragments, phenol/chloroform extraction and ethanol precipitation. DNA sequencing and 
oligo synthesis was performed by the service of the Eurofins MWG (Ebersberg-Germany) and 
sequences were analysed using the gENTLE sequence analysis software (Magnus Manske, 
Cologne). 
4.2.4 Polymerase Chain Reaction (PCR) 
For several cloning strategies PCR were performed to amplify DNA fragments. The Expand High 
Fidelity PCR System (Roche) was used at a concentration of 2.6 U/reaction in combination with 
0.25 µM of both sense and antisense primers, 0.25 mM dNTP mix, 1x reaction buffer and 10 ng 
plasmid DNA as template in 25 µl reaction volume. The template DNA was denatured at 95°C for 
2 min followed by 35 rounds of amplification each consisting of 1 min at 95°C, 1 min at the 
appropriate annealing temperature, and 1 min per kb length of the amplified DNA fragment at 
72°C for elongation. Based on the number of specific nucleotides in the primer, the following 
formula was used to estimate the melting temperature of primers: Tm=2(A+T)+4(G+C). 
For genotyping and deletion PCRs, REDTaq ReadyMix PCR kit with MgCl2 (Sigma) was used 
with primers noted in Table-2. 
4.2.5 Southern Blot 
DNA samples were digested with restriction enzymes and run for 24-30 h at 25 V on 0.8% 
agarose. Southern blotting was carried out by standard capillary methods (Sambrook et al.,  1989) 
onto Hybond-N (GE Healthcare). After DNA transfer, the membrane was incubated at 80°C for 1 
h to fix the DNA permanently to the membrane. 5´, 3´and Neo probes were amplified by PCR, run 
in 0.8% agarose gel and extracted using the QIAquick gel extraction kit. Radioactive labelling 
was performed applying 50-100 ng of DNA. The probes were labeled with [α32P]-dCTP 
(Amersham Pharmacia Biotech) using the Ladderman™ Labelling Kit (Takara) and purified using 
ProbeQuant™ G-50 Micro Columns (GE Healthcare). 
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The membrane was pre-hybridized in QuickHyb hybridization solution (Stratagene) at 65°C for 
60 min. For hybridization of the DNA fragments, the radiolabelled probe was added and 
incubated at 65°C overnight. After washing the blot in wash buffer (2X SSC) the DNA fragments 
were visualized with the x-ray film (Kodak Biomax MS). 
4.2.6 Bacterial Transformation 
The E.coli strain DH5α was cultured as described elsewhere (Sambrook et al., 1989). For 
transformation and production of chemically competent DH5α, the method of Hanahan was 
applied (Hanahan, 1983). 
 
4.3 Molecular RNA techniques 
4.3.1 RNA isolation from cells 
Isolation of RNA from cultured keratinocytes was achieved using RNeasy mini kit (Quiagen) 
according to the manufacturer´s instructions. 
4.3.2 cDNA synthesis 
For first strand cDNA synthesis of RNA, random primers in combination with Superscript II 
Reverse transcriptase (Invitrogen) were used according to the manufacturer’s protocol. 
4.3.3 Semi-quantitative RT-PCR 
Semi-quantitative RT-PCR was performed using REDTaq ReadyMix. 1 µl of synthesized 
cDNA per reaction was used as template under either 30 or 40 cycles of PCR amplification. 
 
4.4 Barrier function assays for epidermis and keratinocytes 
4.4.1 Measurement of transepidermal water loss  
Transepidermal Water Loss (TEWL) of 1-day-old mice was measured using a Tewameter TM-
300 (Courage and Khazaka) equipped with a small-diameter (3 mm) probe and measurements 
were digitally recorded via a MPA5 mulitprobe adapter. Measurements were performed on belly 
skin until there was no fluctuation in values and were continued for 10 seconds after reaching a 
constant plateue. Only values obtained from the stabilized late readouts were used for statistical 
quantifications. 
4.4.2 Lucifer yellow assay  
For penetration assays, backs of newborn mice were immersed in 1mM lucifer yellow solution for 
1 h after which the mice were killed (Koch et al, 2000). Frozen sections were counterstained with 
Phalloidin/DAPI and penetration of the dye was assessed by immunofluorescence microscopy. 
4.4.3 Toluidine blue assay  
Toluidine blue dye staining of embryos was carried out as described (Koch et al, 2000). 
Developmental stages of mice were determined by assuming that fertilization occurred in the 
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middle of the dark cycle the day before plugs were identified. Embryos were incubated for 1 min 
in 25, 50, and 75% methanol in PBS, followed by 1-min incubation in 100% methanol, and a 
descending series of incubations in 75, 50, and 25% methanol in PBS for 1 min. Embryos were 
then washed in PBS for 1 min and stained with 0.1% toluidine blue for 10 min. After staining, 
embryos were embedded in agarose and photographed using Olympus E-620 digital camera. 
Images were processed with Adobe Photoshop. 
4.4.4 Inside-out barrier assay with sulfo-NHS-Biotin 
TJ permeability assay using surface biotinylation technique was performed as described before 
(Furuse et al., 2002). 50 µl of 10 mg/ml EZ-Link™ Sulfo-NHS-Biotin (MW, 443 Daltons) in PBS 
containing 1 mM CaCl2 was injected into the dermis on the back of the Ctrl and dkoepi-/- newborns. 
After 30 min incubation, the skin biopsies were taken out, embedded in tissue-tec solution and 
frozen on dry ice. About 5 µm-thick frozen sections were used for immunofluorescence analysis.  
4.4.5 Transepithelial resistance measurement  
5x105 keratinocytes were plated on collagen 1 coated polycarbonate filter inserts (pore size 0.4 
µm, Millipore) in a 24 well format. One day after plating, junction and barrier formation was 
induced by Ca2+ switch and electrical resistance was measured at indicated time points by using 
the automated ohmmeter (cellZscope) from nanoAnalytics (Münster-Germany). 
4.5 Retinal vascular barrier assay 
4.5.1 Perfusion with 2000 kDa FITC-dextran 
Dkove-/- and control mice were perfused with 200 µl of a 50 mg/ml solution of 2000 kDa FITC-
dextran (sigma) prepared in PBS via left cardiac ventricule. After 5 min of perfusion, the eyes 
were extracted, fixed overnight in PFA and cornea was cut out under a stereomicroscope with a 
pair of spring scissors.  
4.5.2 Systemic infusion with sulfo-NHS-Biotin 
The experimental mice were intravenously injected with 100 µl of biotin (Cyanagen, Italy) 
solution (50 mg/ml in PBS) using a G-30 needle. The tracer was allowed to circulate for 10 min, 
after which, the mice were sacrificed and the eyes were fixed in 4% PFA overnight.  
4.5.3 Preparation of retinal wholemounts 
Using fine scissors, the retinas were separated from sclera and four radial incisions were made in 
3, 6, 9 and 12 o’clock positions. Retinas were flattened using fine brush tips with Internal 
Limiting Membrane (ILM) facing upward in Gelvatol and covered by round cover slips. The 
cover slips were sealed with nail polish the next day to prevent tissue drying. The imaging and 
photo acquisition was performed with a fluorescent camera. 
4.6 Sample preparation and immunoblots analysis 
4.6.1 Separation of the epidermis from dermis  
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Epidermis was separated from the dermis by floating skin biopsies, epidermis side up, in a 0.5 M 
Ammonium thiocyanate (NH4SCN) solution prepared in phosphate buffer, (0,1M Na2HPO4, 0,1M 
KH2PO4, pH6.8) for 20 min on ice. Epidermis was either snap frozen in liquid nitrogen or 
immediately processed for protein isolation. 
4.6.2 Immunoblot analysis of primary keratinocytes and epidermis  
Cultured keratinocytes were lysed in NP40 buffer (1% NP40, 0.1% SDS, 0.5% sodium 
deoxycholate, 150 mM NaCl, 50 mM Tris-HCl pH7.4). After 10 min incubation on ice, the cells 
were harvested with a cell scraper and transferred to a reagent tube. Lysates were cleared by 
centrifugation at 13000 rpm for 10 min at 4°C. Protein concentrations were determined using 
Bradford assay (Biorad). Lysates were diluted in Laemmli buffer, heated for 5 min at 95°C and 50 
µg of total protein was separated by SDS-PAGE on either 7% or 4-12% precast gels (NuPage 
system) and transferred to nitrocellulose according standard blotting procedures. Membranes were 
blocked with 5% non fat dry milk (Haerschle) in TBS-T (0.1% Tween 20, 137 mM NaCl, 20 mM 
Tris-HCl pH7.5) and incubated with the primary antibody diluted in blocking solution overnight 
at 4°C. After wash steps in TBS-T, the membranes were incubated with the appropriate 
horseradish peroxidase-coupled secondary antibody. Immunoreactive proteins were detected by 
enhanced chemiluminescence using either the SuperSignal West Pico or SuperSignal West Femto 
kit (Pierce). 
Frozen epidermal splits were thawed and homogenized in 2 ml Eppendorf tubes by Retsch Mixer 
Mill MM 400 (Düsseldorf, Germany) using little steel balls for 3 min. Epidermal samples were 
lysed with Urea buffer (100 mM NaH2PO4, , 8 M Urea, 10 mM Tris-HCl pH 8) and spun down to 
obtain a cleared supernatant. All other protein assays were similar to keratinocytes except the 
samples were not denatured by heating to avoid covalent modification of peptides in the presence 
of Urea. For filaggrin immunoblots, native 4-16% polyacrylamide gels (Invitrogen) were run with 
SDS-PAGE. 
4.6.3 Quantification of immunoblot bands with ImageJ  
Quantification of the bands was performed by selecting the area, mean gray value and integrated 
density functions of the ImageJ software on a grayscale picture. To obtain the relative signal 
intensity for each test sample band, the intensity values were divided to their respective β-actin 
band values.  
4.7 Immunofluorescence techniques 
4.7.1 Paraffin embedding of experimental tissues 
Freshly isolated tissue samples, were washed quickly in ice cold PBS and fixed in 4% PFA 
overnight at 4°C. After dehydration, tissues were paraffin embedded and stored at room 
temperature until use. Paraffin embedded samples were cut into 5-6µm thick sections and dried 
overnight on glass slides at 37°C. 
                                                                                                                      Materials and Methods 
 62
Eyes were fixed overnight in Methacarn fixative solution composed of 60% methanol, 30% 1,1,1-
trichlorethane (TCE), 10% acetic acid, followed by dehydration procedure. Fixed samples were 
first incubated with RAS-paraffin No.3 (1 x 2 h 60°C), then RAS-paraffin No.6 (overnight 60°C) 
and were finally embedded in RAS-paraffin No.9.  
4.7.2 Immunofluorescence analysis of keratinocytes and tissue sections 
Keratinocytes were plated in 24 well plates on collagen coated glass cover slips. Differentiation 
was induced by switching from low Ca2+ medium (50 µM) to medium containing 1.8 mM Ca2+ for 
the indicated time points. Cells were washed with PBS and fixed for 10 min either with ice cold 
methanol, 4% PFA/PBS or acetone, respectively depending on the antibody used in the 
experiment. 4% PFA/PBS fixed cells were permeabilized by 5 min incubation with 0.5% Triton 
X-100/PBS. After 3 rinses in PBS, unspecific binding sites were blocked with 1% BSA/PBS for 
30 min. All antibodies (see Table-3) were diluted in blocking solution and incubated overnight at 
4°C, followed by 3 washes in blocking solution for each 5 min. After washing, cover slips were 
incubated with appropriate secondary antibodies coupled to either Alexa 488 or Alexa 594 (see 
Table-4). Nuclei were counterstained with either DAPI or propidium iodide. Cover slips were 
mounted with gelvatol on microscope slides (VWR).  
Frozen sections were analysed similar to keratinocytes but paraffin sections were 
deparaffinized, rehydrated in ethanol series and washed twice in PBS. Afterwards the samples 
were unmasked using the antigen retrieval buffer A (EMS) in Retriever (PickCell 
Laboratories, Netherlands).  
Photos were taken with a NIKON Eclipse E800 microscope equipped with a NIKON DMZ1200 
camera or an Olympus IX81 microscope with the digital camera cool snapTM HQ2 
(photometrics). Photos were stored with the software Softworx 3.6.1 (Applied Precision) and 
pictures were processed with Adobe Photoshop and ImageJ. 
4.7.3 Immunofluorescent labelling of biotin in retinal wholemounts 
The retinas were removed and fixed for 10 min in ice-cold acetone followed by two washes in 
PBS for 20 min. The samples were blocked for 2 h in blocking buffer (20% normal goat serum 
with 0.05% TWEEN 20). After 2 washes with PBS, samples were incubated for 1 h with Alexa 
fluor 488-conjugated Streptavidin, supplemented with 0.2% fish skin gelatine and 0.1% TWEEN 
20 in PBS.  After two washes with PBS and 10 min post fixation step in PFA, the retinas were 
flatmounted on glass slides as mentioned above. 
 
4.8 Primary keratinocyte and endothelial cell culture 
4.8.1 Isolation and culture of primary keratinocytes 
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The experiments described were performed with primary keratinocytes isolated from K14Cre/+; 
IGF-1Rfl/fl (IGF-1R-/-) and IGF-1Rfl/fl (ctrl) mice. All experiments were done under sterile 
conditions.  
Epidermis of newborn pups was separated from dermis by overnight trypsin digestion and 
subsequent mechanical stripping. Epidermis was chopped into peaces and agitated in low Ca2+ (50 
µM) keratinocyte medium at 37°C for 1 h. Cell suspension was plated on collagen type 1 coated 
dishes (0.03 mg/ml) in co-culture with a J2 3T3 fibroblast feeder layer.  
Keratinocyte cell culture medium 
     - DMEM (FAD)-medium (Growth medium for keratinocytes) 
- Insulin5 µg/ml 
- Chelated FCS 10% 
- L-glutamine2 mM 
- Cholera toxin 10-10 M 
- Hydrocortisone 0.4 µg/ml 
- Epidermal growth factor 10 ng/ml 
- Penicillin (100 units/ml) and streptomycin (100 µg/ml)  
PBS: Dulbecco´s phosphate buffered saline without calcium and magnesium 
Trypsin: 1x trypsin/ EDTA, 0.05 % (w/v)  
4.8.2 Splitting 
In order to split the cells, growth medium was removed and the cells were washed twice with PBS 
and trypsinized for approximately 10 min at 37 °C. Trypsin was inactivated by adding 3 fold 
amount of complete medium. The suspension was transferred into a 15 ml falcon and centrifuged 
at 800 rpm for 5 min. The supernatant was discarded and cells were resuspended in required 
volume of growth medium and plated on newly coated 6 cm dishes. 
4.8.3 Differentiation and induction by Ca2+ switch 
Confluent keratinocytes were differentiated by raising calcium level from 50 µM to 1.8 mM and 
subsequent incubation for indicated time points.  
4.8.4 Mouse Lung Endothelial Cells (MLECs) isolation  
For endothelial cell isolation, lungs from either Tie2CreERT2/+ IR/IGF-1Rfl/fl or Tie2CreERT2+/+ 
IR/IGF-1Rfl/fl were aseptically removed and homogenized by a combination of mechanical and 
enzymatic digestion with sharp blades and type 1 collagenase. Collagenase treatment of the 
minced tissue was conducted with gentle agitation at 37°C for 30 min. The single cells were 
subject to two rounds of positive selection using PECAM-1 conjugated dynabeads before plating 
and later in passage-0 after reaching confluency. Endothelial cells in all steps were grown on 
plastic dishes coated with gelatine (0.1% v/v) /fibronectin (10 µg/ml) /collagen (10 µg/ml). Wash 
and splitting steps were similar to keratinocytes. 
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Endothelial cell culture medium 
The growth medium was purchased from Promocell (Heidelberg-Germany) with following 
composition: 
- DMEM medium 
- Heparin 90 µg/ml 
- Fetal Calf Serum 0.02 ml/ml 
- Hydrocortisone 1 µg/ml 
- 10 ng/ml epidermal growth factor (EGF) 
- Endothelial Cell Growth Supplement 0.004 ml/ml 
- Penicillin (100 units/ml) and streptomycin (100 µg/ml)  
- Epidermal Growth Factor (recombinant human) 0.1 ng/ml 
- Basic Fibroblast Growth Factor (recombinant human) 1 ng/ml 
4.8.5 HTNC treatment of primary endothelial cells  
4x105 primary endothelial cells were grown in a 10 cm dish and allowed to attach to the plate. 
HTNC protein at 5 µM in a 1:1 mixture of DMEM/PBS (without FCS and other additives) was 
sterilized with syringe-attached filters and diluted serially to obtain two fold dilution series. After 
overnight incubation, the cells were washed twice with PBS and fresh medium was added.  
4.8.6 Tamoxifen treatment of primary endothelial cells 
48 mM stock solution of 4-Hydroxy-Tamoxifen (OHT) was prepared by dissolving and vortexing 
5 mg of OHT in 296 µl of 100% EtOH. This stock was further diluted to make a working stock of 
4 mM solution in 100% EtOH. Finally, the cells were treated with 2 µM OHT in growth medium 
overnight. 
4.9 Corneocyte and lipid analysis 
4.9.1 Cornified envelope preparations 
The ears from mice were excised and heated for 10 min in cornified envelope extraction buffer: 
0.1 mM Tris (pH 8) and 20 mM DTT, 5 mM EDTA, 2% SDS (Hohl et al., 1991) at 96°C, 
cornified envelopes were collected by centrifugation and were resuspended in TE buffer (10 mM 
Tris, 1 mM EDTA) and analyzed by phase-contrast microscopy (Olympus CKX41 microscope).  
4.9.2 Analysis of corneocytes by ImageJ 
The area and circularity indices of the photographed corneocytes were measured using area and 
circularity functions of the ImageJ software after defining a scale bar with equal size for ctrl and 
dkoepi-/- mice. In total, 100 corneocytes were analyzed for each mouse and the data were analyzed 
by statistical software GraphPad Prism 5. 
4.9.3 Lipid extraction and analysis 
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Epidermal free lipids were extracted from 3 mg of dry stratum corneum of different newborn 
skins. The lipid were analysed by thin layer chromatography using a solution containing 
chloroform/methanol/glacial acetic acid 190:9:1 (v/v/v) in the Lipidomics facility of the 
University of Cologne.  
4.9.4 Ceramide nomenclature legend  
Sphingoid bases: 
S = Sphingosine 
P = Phytosphingosine 
H = 6-Hydroxysphingosine 
Fatty acids: 
N = not hydroxylated 
A = α-hydroxylated 
O = ω-hydroxylated 
E = esterified with linoleic acid 
 
 
Table-2: List of primers and their respective PCR products 
Primer ID Sense primer Antisense primer Product 
Cldn1sense 
antisense 
TCTACGAGGGACTGTGGATG TCAGATTCAGCAAGGAGTCG Cldn-1 RT-PCR 
600bp5'/1kb3 TCCCTCAGGCTTCATCCGCAA CTTCAGCTTTGCAGGTGCACG IGF-1R wt/flox typing 
IR5´/IR3´ CTGAATAGCTGAGACCACAG GATGTGCACCCCATGTCG IR wt/flox typing 
IGF-1R Del 5' 
1kb3 
TTATGCCTCCTCTCTTCATC CTTCAGCTTTGCAGGTGCACG IGF-1R deletion PCR 
forinsulInt-5 
revInsulInt-3 
ACGCCTACACATCACATGCATATG CCTCCTGAATAGCTGAGACCACAG IR deletion PCR 
5 floxedpar3 in 
int/ 3-floxedpar3 
in la 
GCCCTGTGTGAGCATTACTG 
 
TCCCTGGAACTGAGGAAGAC 
 
Par-3 wt/flox typing 
K14-2202snew 
CreSL2as 
GATGAAAGCCAAGGGGAATG 
 
CATCACTCGTTGCATCGACC 
 
K-14 Cre transgene typing 
SC1_for  
SC3_rev 
GTCCAATTTACTGACCGTACAC 
 
CTGTCACTTGGTCGTGGCAGC 
 
Tie2creERT2 transgene 
typing 
3probe5-par3 
3probe3-par3 
TAGCAGCATGGGAAGTAAATG 
 
GACAATCTGAGCTCATGTTAC 
 
Par-3 exon4, 3´probe 
Scai-5-5-1-560 
Scai-5-3-1-560 
TCAGGAGATTCTGATCCCAC 
 
AAAGGGGAGAACAGGACAC 
 
Par-3 exon4, 5´probe 
Par-3, Primer 1 
Par-3, Primer 2 
CCTGCGTACAGTCTCCCGGC 
 
AGCTGTCGTGGACCAGCGGGT 
 
Par-3, 1st ATG site  
in exon 1 
Par-3, Primer 3 
Par-3, Primer 2 
CGCGACAGGTAGAAGCATCCATC 
 
AGCTGTCGTGGACCAGCGGGT 
 
Par-3, 2nd  ATG site 
in exon 4 
Par-3, Primer 4 CACCGCCCTCGGCCACGAATC TTGCCGTAGACGCTGTATCCG Stop site for Par-3 variant 3 
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Par-3, Primer 5   
Par-3, Primer 4 
Par-3, Primer 6 
CACCGCCCTCGGCCACGAATC 
 
GGCTTTGTGCACACAAGGCAG 
 
Stop site for Par-3 variant 1 
Par-3, Primer 7 
Par-3, Primer 8 
GGGAGCCCTGCTGCACCTGAG 
 
GTCCATAAGTCCCAGGACATG 
 
Stop site for Par-3 variant 2 
GAPDH for 
GAPDH rev 
TGCCCCCATGTTTGTGATG  
 
TGTGGTCATGAGCCCTTCC  
 
GAPDH RT-PCR 
for-sapar3-1 
3-floxedpar3 in la 
GCCCTGGCTATCCTGAAACT 
 
TCCCTGGAACTGAGGAAGAC 
 
Par-3 deletion PCR 
5-kpn-f6-431 
R2.3 neo63 
AATAGTAACCACCCTGGACC 
 
TCCAGACTGCCTTGGGAAAA 
 
Par-3 ES cell screening of 
Short arm-Neo- 4.3 kb 
Forloxp-la 
3probe3-par3 
 
GCTATACGAAGTTATAAGCTTAAG
C 
 
GACAATCTGAGCTCATGTTAC 
 
Par-3 ES cell screening of 
Long arm-3´Loxp- 5.63 kb 
5saparnoti-2 
3sapardavr 
GCGGCCGCTGTATGGCTCTGACTT
GAAGACAACAAC 
 
CCTAGGATCCGATTGAATTCAGAT
CTTTAGAC 
Par-3 short arm 3.7 kb PCR 
5flpardAsc 
3flpardmfe 
 
GGCGCGCCTTCAATCCCACATGAT
AGGA 
 
CAATTGGATCCATCAGAAGATCAT
ACT 
 
Par-3 floxed exon4 PCR, 622 
pbs 
5lapardXhoi 
3lapardpme 
 
CTCGAGGATATCGTGTTTTGAAAT
GATAATATATCAG 
 
GTTTAAACCTAGGGAAGAGTGCAA
TTCTC 
 
Par-3 long arm 5 kb PCR 
ForNeoprobe553 
RevNeoprobe553 
TGAATGAACTGCAGGACGAGGCA ATTGCTGAAGAGCTTGGCGGC Neo probe for southern blot 
 
Table-3: Primary antibodies  
Antigene Source Working 
dilution 
Catalog 
number 
company 
Filaggrin Rabbit WB:1/1000 
IF: 1/500 
PRB-417P Convance 
Loricrin Rabbit WB:1/1000 
IF: 1/500 
PRB-145P Convance 
Involucrin Rabbit WB:1/1000 
IF: 1/500 
PRB-140C Convance 
Casp-14 Rabbit WB:1/2000 
IF: 1/1000 
 From 
P.Vandenabeele 
Ghent-Belgium 
Cldn-1 Rabbit WB:1/1000 
IF: 1/500 
51-9000 
 
Zymed 
ZO-1 Rabbit WB:1/1000 
IF: 1/500 
61-7300 
 
Zymed 
β-catenin Rabbit WB:1/1000 RMA-12741. Epitomics 
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IF: 1/500 Lot:Yf060402r 
PECAM-1 Rat Coating 
Dynabeads:1/1000 
553708 BD Pharmingen 
Actin 
 
Mouse WB 1/10000  C4, 
Sigma Aldrich 
 
Table-4: Secondary antibodies  
Antigene Source Working 
dilution 
Catalog 
number 
company 
Alexafluor 488 
anti-rabbit 
Goat IF 1/500 A21206 Molecular 
Probes 
Alexafluor 488 
Streptavidin 
 IF 1/500 S32354 Molecular 
Probes 
Phalloidin 
TRITC 
Amanita 
Phalloides 
IF 1/500 P-1951 Sigma 
Anti-Rat IgG 
Dynabeads 
Sheep  11035 Invitrogen 
IgG-HRP      
anti-rabbit 
Goat WB 1/5000  BioRad 
IgG-HRP anti-
mouse 
Goat WB 1/5000  BioRad 
Alexafluor 594 
anti-rabbit 
Donkey IF 1/500 A21207 Invitrogen 
 
5 Abbreviations 
BSA bovine serum albumin 
Bp base pairs 
BRB blood retinal barrier 
C carbon atom 
°C degree Celsius 
CAP channel-activating serine protease 
cDNA complementary DNA 
CE cornified envelope 
Cer Ceramide 
Cre site specific recombinase from phage P1(causes recombination) 
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DAPI 4`6-Diamidino-2-phenylindol 
DKO double knockout 
DNA deoxyribonucleic acid 
DMSO dimethylsulfoxide 
DR diabetic retinopathy 
E embryonic day 
ECL enhanced chemiluminescence 
EDTA ethylene diamine tetra acetic acid 
EGF epidermal growth factor 
ENaC epithelial sodium channel 
ERT estrogen receptor  
EtOH ethanol 
FCS fetal calf serum 
Fig figure 
FLG filaggrin  
floxed/lox lox P flanked 
Foxo1 forkhead-O transcription factor 1 
GAPDH Glycerinaldehyd-3-phosphat-Dehydrogenase 
GlcCer Glucosylated ceramide 
GTP Guanosintriphosphat 
HTNC His-Tat-NLS-Cre 
g gram 
h hours 
H&E hematoxylin/eosin 
HRP horse radish peroxidase 
Hz hertz 
IF immunofluorescent 
IGF-1 insulin-like growth factor 1 
IGF-1R insulin-like growth factor 1receptor 
IR insulin receptor 
K keratin 
Kb Kilo base 
kDa kilo Dalton 
KO knockout 
LCE late cornified envelope  
LY lucifer yellow 
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mg milligram 
min minute 
µl micro liter 
ml Milliliter: 
µm micro molar 
mM millimolar 
mRNA messenger RNA 
n nano 
NeoR Neomycin resistance 
NGS normal goat serum 
NVU neurovascular unit 
OIR oxygen-induced retinopathy  
P postnatal day 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PI3K phosphatidylinositol 3 kinase 
PIP2 phosphatidylinositol (4,5) biphosphate 
PIP3 phosphatidylinositol (3,4,5) triphosphate 
PFA paraformaldehyde 
PMSF phenylmethylsulphonylfluorid 
Prss8 protease serine S1 family member 8  
RAS-paraffin Richard-Allan Scientific paraffin 
Rac1 Ras-related C3 botulinum toxin substrate 1 
RNA ribonucleic acid 
RNase ribonuclease 
ROP retinopathy of prematurity 
RT real time 
rpm rounds per minute 
SC stratum corneum 
SDS sodium dodecyl sulphate 
Sprr Small prolie rich protein 
TBS tris buffered saline 
TE Tris-EDTA buffered  
TEWL transepidermal water loss  
            Tie2 Tyrosine kinase with immunoglobulin and epidermal growth factor homology 
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domains-2 
Tween polyoxethylene-sorbitan-monolaureate 
U unit 
vs. versus 
v/v volume/volume 
w/v weight per volume 
WB western blot  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                      Materials and Methods 
 71
6 References: 
Abbas A, Grant PJ, Kearney MT. Role of IGF-1 in glucose regulation and cardiovascular disease. 
Expert Rev Cardiovasc Ther. 2008 Sep; 6(8):1135-49. 
Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, José PA, Taylor SI, 
Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor 
gene. Nat Genet. 1996 Jan; 12(1):106-9. 
Anderson JM, Van Itallie CM, Fanning AS. Setting up a selective barrier at the apical junction 
complex. Curr Opin Cell Biol. 2004 Apr; 16(2):140-5. 
Arnqvist HJ. The role of IGF-system in vascular insulin resistance. Horm Metab Res. 2008 Sep; 
40(9):588-92 
Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of 
endothelial junctions is reflected by differential expression and specific subcellular localization of 
the three JAM family members. Blood. 2001 Dec 15; 98(13):3699-707. 
Backendorf C, Hohl D. A common origin for cornified envelope proteins? Nat Genet. 1992 Oct; 
2(2):91. 
Barber AJ, Antonetti DA.Mapping the blood vessels with paracellular permeability in the retinas 
of diabetic rats. Invest Ophthalmol Vis Sci. 2003 Dec; 44(12):5410-6. 
Barreca A, De Luca M, Del Monte P, Bondanza S, Damonte G, Cariola G, Di Marco E, Giordano 
G, Cancedda R, Minuto F. In vitro paracrine regulation of human keratinocyte growth by 
fibroblast-derived insulin-like growth factors. J Cell Physiol. 1992 May; 151(2):262-8. 
Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B.The IGF-I receptor in cell growth, 
transformation and apoptosis. Biochim Biophys Acta. 1997 Jun 7; 1332(3):F105-26. 
Bennett WR, Crew TE, Slack JM, Ward A. Structural-proliferative units and organ growth: 
effects of insulin-like growth factor 2 on the growth of colon and skin. Development. 2003 Mar; 
130(6):1079-88. 
Benton R, St Johnston DA conserved oligomerization domain in drosophila Bazooka/PAR-3 is 
important for apical localization and epithelial polarity. Curr Biol. 2003 Aug 5; 13(15):1330-4. 
Benyoucef S, Surinya KH, Hadaschik D, Siddle K. Characterization of insulin/IGF hybrid 
receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced 
exon 11 sequence to ligand binding and receptor activation. Biochem J. 2007 May 1; 403(3):603-
13. 
Bernstein MH, Hollenberg MJ. Fine structure of the choriocappillaris and retinal capillaries. 
Invest Ophthalmol. 1965 Dec; 4(6):1016-25. 
Binczek E, Jenke B, Holz B, Günter RH, Thevis M, Stoffel W. Obesity resistance of the stearoyl-
CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier 
and adaptive thermoregulation. Biol Chem. 2007 Apr; 388(4):405-18. 
                                                                                                                                  References 
 72
Bol DK, Kiguchi K, Gimenez-Conti I, Rupp T, DiGiovanni J. Overexpression of insulin-like 
growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in 
transgenic mice. Oncogene. 1997 Apr 10; 14(14):1725-34. 
Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, Accili D, Goodyear LJ, Kahn CR. 
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of 
NIDDM without altering glucose tolerance. Mol Cell. 1998 Nov; 2(5):559-69. 
Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev 
Mol Cell Biol. 2005 Apr; 6(4):328-40. 
Cardoso FL, Brites D, Brito MA. Looking at the blood-brain barrier: molecular anatomy and 
possible investigation approaches. Brain Res Rev. 2010 Sep 24; 64(2):328-63.  
Chao W, D'Amore PA. IGF2: epigenetic regulation and role in development and disease. 
Cytokine Growth Factor Rev. 2008 Apr; 19(2):111-20.  
Chen X, Macara IG. Par-3 controls tight junction assembly through the Rac exchange factor 
Tiam1. Nat Cell Biol. 2005 Mar; 7(3):262-9.  
Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007; 10(2):133-40. 27. 
Clauser E. (1994) Insulin receptor and diabetes   Rev Prat. May 1; 44(9):1154-62. 
Dale BA, Resing KA, Presland RB. Keratohyalin granule proteins. In: Leigh I, Lane B, Watt F 
(eds). The Keratinocyte Handbook. Cambridge: Cambridge University Press, 1994, pp 323-350 
Davidson MK, Russ PK, Glick GG, Hoffman LH, Chang MS, Haselton FR. Reduced expression 
of the adherens junction protein cadherin-5 in a diabetic retina. Am J Ophthalmol. 2000 Feb; 
129(2):267-9. 
Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic 
acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989 Feb; 10(1):68-91. 
De Meyts P, Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug 
design. Nat Rev Drug Discov. 2002 Oct; 1(10):769-83. 
Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S, Van den Broecke C, Van 
Damme P, D'Herde K, Hachem JP, Borgonie G, Presland RB, Schoonjans L, Libert C, 
Vandekerckhove J, Gevaert K, Vandenabeele P, Declercq W. Caspase-14 protects against 
epidermal UVB photodamage and water loss. Nat Cell Biol. 2007 Jun; 9(6):666-74.  
Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol. 2004 Apr; 
5(4):261-70. 
Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Ward CW, Wallace JC.  
Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor 
(IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol. 2004 Oct; 18(10):2502-12.  
Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE. Molecular interactions of the IGF 
system. Cytokine Growth Factor Rev. 2005 Aug-Oct; 16(4-5):421-39. 
                                                                                                                                  References 
 73
DiGiovanni J, Bol DK, Wilker E, Beltrán L, Carbajal S, Moats S, Ramirez A, Jorcano J, Kiguchi 
K. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic 
mice leads to spontaneous tumor promotion. Cancer Res. 2000 Mar 15; 60(6):1561-70. 
Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K. Sphingolipid 
activator proteins are required for epidermal permeability barrier formation. J Biol Chem. 1999a 
Apr 16; 274(16):11038-45. 
Doering T, Proia RL, Sandhoff K. Accumulation of protein-bound epidermal glucosylceramides 
in beta-glucocerebrosidase deficient type 2 Gaucher mice. FEBS Lett. 1999b Mar 26; 447(2-
3):167-70. 
Doering T, Brade H, Sandhoff K. Sphingolipid metabolism during epidermal barrier development 
in mice. J Lipid Res. 2002 Oct; 43(10):1727-33. 
Duncan FE, Moss SB, Schultz RM, Williams CJ. PAR-3 defines a central subdomain of the 
cortical actin cap in mouse eggs. Dev Biol. 2005 Apr 1; 280(1):38-47. 
Ebnet K, Suzuki A, Horikoshi Y, Hirose T, Meyer Zu Brickwedde MK, Ohno S, Vestweber D. 
The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule 
(JAM). EMBO J. 2001 Jul 16; 20(14):3738-48. 
Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, Zander K, Meyer zu Brickwedde MK, 
Suzuki A, Imhof BA, Vestweber D. The junctional adhesion molecule (JAM) family members 
JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in 
endothelial cell polarity. J Cell Sci. 2003 Oct 1; 116(Pt 19):3879-91. 
Ebnet K, Suzuki A, Ohno S, Vestweber D. Junctional adhesion molecules (JAMs): more 
molecules with dual functions?J Cell Sci. 2004 Jan 1; 117(Pt 1):19-29. 
Eckert RL, Green H.Structure and evolution of the human involucrin gene. Cell. 1986 Aug 15; 
46(4):583-9. 
Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF. Involucrin--structure and role in 
envelope assembly. J Invest Dermatol. 1993 May; 100(5):613-7. 
Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ. 
Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in 
MCF-7 breast cancer cells. Mol Endocrinol. 1996 Mar; 10(3):286-97. 
Epp N, Fürstenberger G, Müller K, de Juanes S, Leitges M, Hausser I, Thieme F, Liebisch G, 
Schmitz G, Krieg P. 12R-lipoxygenase deficiency disrupts epidermal barrier function. J Cell Biol. 
2007 Apr 9; 177(1):173-82. 
Erickson KK, Sundstrom JM, Antonetti DA. Vascular permeability in ocular disease and the role 
of tight junctions. Angiogenesis. 2007; 10(2):103-17.  
Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. Ligand-activated site-specific 
recombination in mice. Proc Natl Acad Sci U S A. 1996 Oct 1; 93(20):10887-90. 
                                                                                                                                  References 
 74
Feng W, Wu H, Chan LN, Zhang M. Par-3-mediated junctional localization of the lipid 
phosphatase PTEN is required for cell polarity establishment.  J Biol Chem. 2008 Aug 22; 
283(34):23440-9.  
Feng Z, Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the 
p53 protein. Trends Cell Biol. 2010 Jul; 20(7):427-34.  
Forde A, Constien R, Gröne HJ, Hämmerling G, Arnold B. Temporal Cre-mediated 
recombination exclusively in endothelial cells using Tie2 regulatory elements. Genesis. 2002 
Aug; 33(4):191-7. 
Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R.  The role of insulin 
receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 2008 Feb; 
114(1):23-37. 
Frystyk J. Free insulin-like growth factors -- measurements and relationships to growth hormone 
secretion and glucose homeostasis. Growth Horm IGF Res. 2004 Oct; 14(5):337-75. 
Fernández AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, 
Shulman GI, Le Roith D. Functional inactivation of the IGF-I and insulin receptors in skeletal 
muscle causes type 2 diabetes. Genes Dev. 2001 Aug 1; 15(15):1926-34. 
Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Occludin: a novel 
integral membrane protein localizing at tight junctions. J Cell Biol. 1993 Dec; 123(6 Pt 2):1777 
88. 
Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane 
proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998a 
Jun 29; 141(7):1539-50. 
Furuse M, Sasaki H, Fujimoto K, Tsukita S.  A single gene product, claudin-1 or -2, reconstitutes 
tight junction strands and recruits occludin in fibroblasts. J Cell Biol. 1998b Oct 19; 143(2):391-
401. 
Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S. 
Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from 
claudin-1-deficient mice. J Cell Biol. 2002 Mar 18; 156(6):1099-111.  
Gan SQ, McBride OW, Idler WW, Markova N, Steinert PM. Organization, structure, and 
polymorphisms of the human profilaggrin gene. Biochemistry. 1990 Oct 9; 29(40):9432-40. 
Gao L, Macara IG, Joberty G. Multiple splice variants of Par3 and of a novel related gene, Par3L, 
produce proteins with different binding properties. Gene. 2002 Jul 10; 294(1-2):99-107. 
Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-
arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006 Nov; 8(11):1223-34.  
                                                                                                                                  References 
 75
Geng S, Mezentsev A, Kalachikov S, Raith K, Roop DR, Panteleyev AA. Targeted ablation of 
Arnt in mouse epidermis results in profound defects in desquamation and epidermal barrier 
function. J Cell Sci. 2006 Dec 1; 119(Pt 23):4901-12.  
Getsios S, Huen AC, Green KJ. Working out the strength and flexibility of desmosomes. Nat Rev 
Mol Cell Biol. 2004 Apr; 5(4):271-81. 
Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P, Backendorf C. Molecular 
characterization and evolution of the SPRR family of keratinocyte differentiation markers 
encoding small proline-rich proteins. Genomics. 1993 Jun; 16(3):630-7. 
González-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys 
Mol Biol. 2003 Jan; 81(1):1-44. 
Guerrin M, Simon M, Montézin M, Haftek M, Vincent C, Serre G. Expression cloning of human 
corneodesmosin proves its identity with the product of the S gene and allows improved 
characterization of its processing during keratinocyte differentiation. J Biol Chem. 1998 Aug 28; 
273(35):22640-7. 
Guttormsen J, Koster MI, Stevens JR, Roop DR, Williams T, Winger QA. Disruption of 
epidermal specific gene expression and delayed skin development in AP-2 gamma mutant mice. 
Dev Biol. 2008 May 1; 317(1):187-95.  
Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, Smyth N, Peters T, Kess D,  
Holtkötter O, Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed 
protein. Genesis. 2004 Apr; 38(4):176-81 
Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983 Jun 5; 
166(4):557-80. 
Hanley K, Jiang Y, Holleran WM, Elias PM, Williams ML, Feingold KR. Glucosylceramide 
metabolism is regulated during normal and hormonally stimulated epidermal barrier development 
in the rat. J Lipid Res. 1997 Mar; 38(3):576-84. 
Hardman MJ, Sisi P, Banbury DN, Byrne C. Patterned acquisition of skin barrier function during 
development. Development. 1998 Apr; 125(8):1541-52. 
Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF 
activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial 
permeability. Invest Ophthalmol Vis Sci. 2006 Nov; 47(11):5106-15. 
Haurigot V, Villacampa P, Ribera A, Llombart C, Bosch A, Nacher V, Ramos D, Ayuso E, 
Segovia JC, Bueren JA, Ruberte J, Bosch F. Increased intraocular insulin-like growth factor-I 
triggers blood-retinal barrier breakdown. J Biol Chem. 2009 Aug 21;284(34):22961-9.  
Hawkins BT, Davis TP.  The blood-brain barrier/neurovascular unit in health and disease. 
Pharmacol Rev. 2005 Jun; 57(2):173-85. 
                                                                                                                                  References 
 76
Heidary G, Vanderveen D, Smith LE. Retinopathy of prematurity: current concepts in molecular 
pathogenesis. Semin Ophthalmol. 2009 Mar-Apr;24(2):77-81. 
Hirose T, Izumi Y, Nagashima Y, Tamai-Nagai Y, Kurihara H, Sakai T, Suzuki Y, Yamanaka T, 
Suzuki A, Mizuno K, Ohno S. Involvement of ASIP/PAR-3 in the promotion of epithelial tight 
junction formation. J Cell Sci. 2002 Jun 15; 115(Pt 12):2485-95. 
Hirose T, Karasawa M, Sugitani Y, Fujisawa M, Akimoto K, Ohno S, Noda T. PAR3 is essential 
for cyst-mediated epicardial development by establishing apical cortical domains. Development. 
2006 Apr; 133(7):1389-98.  
Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF, 
Schlingemann RO. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in 
vivo is predominantly associated with pinocytotic vesicular transport and not with formation of 
fenestrations. Vascular endothelial growth factor-A. Curr Eye Res. 2000 Aug; 21(2):637-45. 
Hohl D, Mehrel T, Lichti U, Turner ML, Roop DR, Steinert PM. Characterization of human 
loricrin. Structure and function of a new class of epidermal cell envelope proteins. J Biol Chem. 
1991 Apr 5; 266(10):6626-36. 
Iden S, Rehder D, August B, Suzuki A, Wolburg-Buchholz K, Wolburg H, Ohno S, Behrens J, 
Vestweber D, Ebnet K.A distinct PAR complex associates physically with VE-cadherin in 
vertebrate endothelial cells. EMBO Rep. 2006 Dec; 7(12):1239-46.  
Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel 
barrier at tricellular contacts of epithelial cells. J Cell Biol. 2005 Dec 19; 171(6):939-45. 
Ishibashi T, Tanaka K, Taniguchi Y. Disruption of blood-retinal barrier in experimental diabetic 
rats: an electron microscopic study. Exp Eye Res. 1980 Apr; 30(4):401-10. 
Izumi Y, Hirose T, Tamai Y, Hirai S, Nagashima Y, Fujimoto T, Tabuse Y, Kemphues KJ, Ohno 
S.An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a 
mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol. 1998 Oct 
5; 143(1):95-106. 
Jennemann R, Sandhoff R, Langbein L, Kaden S, Rothermel U, Gallala H, Sandhoff K, Wiegandt 
H, Gröne HJ. Integrity and barrier function of the epidermis critically depend on 
glucosylceramide synthesis. J Biol Chem. 2007 Feb 2; 282(5):3083-94. 
Johansson A, Driessens M, Aspenström P.  The mammalian homologue of the Caenorhabditis 
elegans polarity protein PAR-6 is a binding partner for the Rho GTPases Cdc42 and Rac1. J Cell 
Sci. 2000 Sep; 113 (Pt 18):3267-75. 
Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated 
endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001 Jan; 158(1):147-52. 
Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, 
Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP. Suppression of Fas-FasL-induced endothelial 
                                                                                                                                  References 
 77
cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-
induced diabetes. FASEB J. 2003 Jan; 17(1):76-8. 
Kalinin AE, Kajava AV, Steinert PM. Epithelial barrier function: assembly and structural features 
of the cornified cell envelope. Bioessays. 2002 Sep; 24(9):789-800 
Kim S, Kang HY, Nam EH, Choi MS, Zhao XF, Hong CS, Lee JW, Lee JH, Park YK. TMPRSS4 
induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 
and its signaling pathways. Carcinogenesis. 2010 Apr; 31(4):597-606. 
Kitamura T, Kahn CR, Accili D. Insulin receptor knockout mice. Annu Rev Physiol. 2003; 
65:313-32. 
Koch PJ, de Viragh PA, Scharer E, Bundman D, Longley MA, Bickenbach J, Kawachi Y, Suga Y, 
Zhou Z, Huber M, Hohl D, Kartasova T, Jarnik M, Steven AC, Roop DR. Lessons from loricrin-
deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a 
major cornified envelope protein. J Cell Biol. 2000 Oct 16; 151(2):389-400. 
 Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR. Knockout 
of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal 
neovascularization. J Clin Invest. 2003 Jun; 111(12):1835-42. 
Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. Conditional vascular cell 
adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp 
Med. 2001 Mar 19; 193(6):741-54. 
Leyvraz C, Charles RP, Rubera I, Guitard M, Rotman S, Breiden B, Sandhoff K, Hummler E. The 
epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol. 2005 Aug 
1; 170(3):487-96. 
Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, Pawson T. A mammalian PAR-3-PAR-6 
complex implicated in Cdc42/Rac1 and aPKC signaling and cell polarity. Nat Cell Biol. 2000 
Aug; 2(8):540-7. 
Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the 
genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993 Oct 
8; 75(1):59-72. 
Lofqvist C, Willett KL, Aspegren O, et al. Quantification and localization of the IGF/insulin 
system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in 
mice. Invest Ophthalmol Vis Sci. 2009; 50:1831–1837. 
Lynley AM, Dale BA. The characterization of human epidermal filaggrin. A histidine-rich, 
keratin filament-aggregating protein. Biochim Biophys Acta. 1983 Apr 14; 744(1):28-35. 
Määttä A, DiColandrea T, Groot K, Watt FM. Gene targeting of envoplakin, a cytoskeletal linker 
protein and precursor of the epidermal cornified envelope. Mol Cell Biol. 2001 Oct; 21(20):7047-
53. 
                                                                                                                                  References 
 78
Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won 
MH, Kim YM, Kwon YG. Endothelial progenitor cell homing: prominent role of the IGF2-
IGF2R-PLCbeta2 axis. Blood. 2009 Jan 1; 113(1):233-43.  
Marenholz I, Zirra M, Fischer DF, Backendorf C, Ziegler A, Mischke D. Identification of human 
epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire 
YACs to a gridded keratinocyte cDNA library. Genome Res. 2001 Mar; 11(3):341-55. 
Markova NG, Marekov LN, Chipev CC, Gan SQ, Idler WW, Steinert PM.  Profilaggrin is a major 
epidermal calcium-binding protein. Mol Cell Biol. 1993 Jan; 13(1):613-25. 
Marshall D, Hardman MJ, Nield KM, Byrne C. Differentially expressed late constituents of the 
epidermal cornified envelope. Proc Natl Acad Sci U S A. 2001 Nov 6; 98(23):13031-6. 
Matsuki M, Yamashita F, Ishida-Yamamoto A, Yamada K, Kinoshita C, Fushiki S, Ueda E, 
Morishima Y, Tabata K, Yasuno H, Hashida M, Iizuka H, Ikawa M, Okabe M, Kondoh G, 
Kinoshita T, Takeda J, Yamanishi K. Defective stratum corneum and early neonatal death in mice 
lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S 
A. 1998 Feb 3; 95(3):1044-9. 
Maxwell DS, Pease DC. The electron microscopy of the choroid plexus. J Biophys Biochem 
Cytol. 1956 Jul 25; 2(4):467-74. 
McKinley-Grant LJ, Idler WW, Bernstein IA, Parry DA, Cannizzaro L, Croce CM, Huebner K, 
Lessin SR, Steinert PM. Characterization of a cDNA clone encoding human filaggrin and 
localization of the gene to chromosome region 1q21. Proc Natl Acad Sci U S A. 1989 Jul; 
86(13):4848-52. 
Mehrel T, Hohl D, Rothnagel JA, Longley MA, Bundman D, Cheng C, Lichti U, Bisher ME, 
Steven AC, Steinert PM, et al. Identification of a major keratinocyte cell envelope protein, 
loricrin. Cell. 1990 Jun 15; 61(6):1103-12. 
Michels C, Aghdam SY, Niessen CM. Cadherin-mediated regulation of tight junctions in 
stratifying epithelia. Ann N Y Acad Sci. 2009 May; 1165:163-8. 
Michels C, Buchta T, Bloch W, Krieg T, Niessen CM. Classical cadherins regulate desmosome 
formation. J Invest Dermatol. 2009 Aug; 129(8):2072-5. 
Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and 
experimental diabetic retinopathy. J Clin Invest. 1996 Jun 15; 97(12):2883-90. 
Moseley WS, Seldin MF. Definition of mouse chromosome 1 and 3 gene linkage groups that are 
conserved on human chromosome 1: evidence that a conserved linkage group spans the 
centromere of human chromosome 1. Genomics. 1989 Nov; 5(4):899-905. 
Moxham CP, Duronio V, Jacobs S. Insulin-like growth factor I receptor beta-subunit 
heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin 
receptor heterodimers. J Biol Chem. 1989 Aug 5; 264(22):13238-44. 
                                                                                                                                  References 
 79
Müller-Decker K, Scholz K, Neufang G, Marks F, Fürstenberger G. Localization of 
prostaglandin-H synthase-1 and -2 in mouse skin: implications for cutaneous function. Exp Cell 
Res. 1998 Jul 10; 242(1):84-91. 
Nagai-Tamai Y, Mizuno K, Hirose T, Suzuki A, Ohno S. Regulated protein-protein interaction 
between aPKC and PAR-3 plays an essential role in the polarization of epithelial cells. Genes 
Cells. 2002 Nov; 7(11):1161-71. 
Näthke IS, Hinck L, Swedlow JR, Papkoff J, Nelson WJ. Defining interactions and distributions 
of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol. 1994 Jun; 
125(6):1341-52. 
Navaratna D, McGuire PG, Menicucci G, Das A. Proteolytic degradation of VE-cadherin alters 
the blood-retinal barrier in diabetes. Diabetes. 2007 Sep; 56(9):2380-7.  
Nemes Z, Marekov LN, Fésüs L, Steinert PM. A novel function for transglutaminase 1: 
attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation. Proc 
Natl Acad Sci U S A. 1999 Jul 20; 96(15):8402-7. 
Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol. 
2007 Nov; 127(11):2525-32. 
Niessen CM, Gottardi CJ. Molecular components of the adherens junction. Biochim Biophys 
Acta. 2008 Mar; 1778(3):562-71.  
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective 
loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003 May 12; 
161(3):653-60. 
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. 
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002 
Oct 10; 347(15):1151-60. 
Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, 
Goldfine ID, Belfiore A. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression 
in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second 
mechanism of IGF-I signaling. Clin Cancer Res. 1999 Jul; 5(7):1935-44. 
Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F. Ability of the hydrophobic FGF and basic 
TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient 
genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A. 2002 Apr 2; 99(7):4489-
94.  
Peng X, Haldar S, Deshpande S, Irani K, Kass DA. Wall stiffness suppresses Akt/eNOS and 
cytoprotection in pulse-perfused endothelium. Hypertension. 2003 Feb; 41(2):378-81. 
                                                                                                                                  References 
 80
Planès C, Randrianarison NH, Charles RP, Frateschi S, Cluzeaud F, Vuagniaux G, Soler P, Clerici 
C, Rossier BC, Hummler E. ENaC-mediated alveolar fluid clearance and lung fluid balance 
depend on the channel-activating protease 1. EMBO Mol Med. 2010 Jan; 2(1):26-37. 
Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer. 2008 
Dec; 8(12):915-28. 
Presland RB, Haydock PV, Fleckman P, Nirunsuksiri W, Dale BA. Characterization of the human 
epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium 
binding domain at the amino terminus. J Biol Chem. 1992 Nov 25; 267(33):23772-81. 
Presland RB, Function of filaggrin and caspase-14 in formation and maintenance of the epithelial 
barrier. Dermatol Sinica 2009; 27: 1-14 
Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Kaplan RC, Muzumdar R, Rohan TE, 
Strickler HD. The role of insulin-like growth factor-I and its binding proteins in glucose 
homeostasis and type 2 diabetes. Diabetes Metab Res Rev. 2009 Jan; 25(1):3-12. 
Rice RH, Crumrine D, Hohl D, Munro CS, Elias PM. Coss-linked envelopes in nail plate in 
lamellar ichthyosis. Br J Dermatol. 2003 Nov; 149(5):1050-4. 
Rothnagel JA, Steinert PM. The structure of the gene for mouse filaggrin and a comparison of the 
repeating units. J Biol Chem. 1990 Feb 5; 265(4):1862-5. 
Rothnagel JA, Longley MA, Bundman DS, Naylor SL, Lalley PA, Jenkins NA, Gilbert DJ, 
Copeland NG, Roop DR. Characterization of the mouse loricrin gene: linkage with profilaggrin 
and the flaky tail and soft coat mutant loci on chromosome 3. Genomics. 1994 Sep 15; 23(2):450-
6. 
Sadagurski M, Weingarten G, Rhodes CJ, White MF, Wertheimer E. Insulin receptor substrate 2 
plays diverse cell-specific roles in the regulation of glucose transport. J Biol Chem. 2005 Apr 15; 
280(15):14536-44.  
Sadagurski M, Nofech-Mozes S, Weingarten G, White MF, Kadowaki T, Wertheimer E. Insulin 
receptor substrate 1 (IRS-1) plays a unique role in normal epidermal physiology. J Cell Physiol. 
2007 Nov; 213(2):519-27.  
Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. Complex 
phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000 
Dec; 11(12):4131-42. 
Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. 
Nature. 2001 Dec 13; 414(6865):799-806. 
Sambrook J. Fritsch E.F. and T. Maniatis. Molecular Cloning A Laboratory Manual. Second 
edition. Cold Spring Harbor Laboratory Press.1989, p.1.74. 
Sandhoff  R. Very long chain sphingolipids: tissue expression, function and synthesis. FEBS Lett. 
2010 May 3; 584(9):1907-13. 
                                                                                                                                  References 
 81
Schmoranzer J, Fawcett JP, Segura M, Tan S, Vallee RB, Pawson T, Gundersen GG. Par3 and 
dynein associate to regulate local microtubule dynamics and centrosome orientation during 
migration. Curr Biol. 2009 Jul 14; 19(13):1065-74.  
Segre JA, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier 
function of the skin. Nat Genet. 1999 Aug; 22(4):356-60. 
Sell C, Ptasznik A, Chang CD, Swantek J, Cristofalo VJ, Baserga R. IGF-1 receptor levels and the 
proliferation of young and senescent human fibroblasts. Biochem Biophys Res Commun. 1993 Jul 
15; 194(1):259-65. 
Sevilla LM, Nachat R, Groot KR, Klement JF, Uitto J, Djian P, Määttä A, Watt FM. Mice 
deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol. 
2007 Dec 31; 179(7):1599-612. 
Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006; 
22:207-35. 
Shakib M, Cunha-Vaz JG.  Studies on the permeability of the blood-retinal barrier. IV. Junctional 
complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. Exp 
Eye Res. 1966 Jul; 5(3):229-34 
Shapiro L, Weis WI. Structure and biochemistry of cadherins and catenins. Cold Spring Harb 
Perspect Biol. 2009 Sep; 1(3):a003053.  
Simon M, Bernard D, Minondo AM, Camus C, Fiat F, Corcuff P, Schmidt R, Serre G. Persistence 
of both peripheral and non-peripheral corneodesmosomes in the upper stratum corneum of winter 
xerosis skin versus only peripheral in normal skin. J Invest Dermatol. 2001 Jan; 116(1):23-30. 
Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 
Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994 Jan; 35(1):101-11. 
Soos MA, Siddle K.Immunological relationships between receptors for insulin and insulin-like 
growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors 
involving hybrids with insulin receptors. Biochem J. 1989 Oct 15; 263(2):553-63. 
Soos MA, Field CE, Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind 
insulin-like growth factor-I, but not insulin, with high affinity. Biochem J. 1993 Mar 1;290 ( Pt 
2):419-26. 
Stachelscheid H, Ibrahim H, Koch L, Schmitz A, Tscharntke M, Wunderlich FT, Scott J, Michels 
C, Wickenhauser C, Haase I, Brüning JC, Niessen CM. Epidermal insulin/IGF-1 signaling control 
interfollicular morphogenesis and proliferative potential through Rac activation. EMBO J. 2008 
Aug 6; 27(15):2091-101.  
Steinert PM, Cantieri JS, Teller DC, Lonsdale-Eccles JD, Dale BA. Characterization of a class of 
cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci U S A. 
1981 Jul; 78(7):4097-101. 
                                                                                                                                  References 
 82
Steinert PM, Marekov LN. Initiation of assembly of the cell envelope barrier structure of stratified 
squamous epithelia. Mol Biol Cell. 1999 Dec; 10(12):4247-61. 
Takada M, Hattori S.Presence of fenestrated capillaries in the skin. Anat Rec. 1972 Jun; 
173(2):213-9. 
Takekuni K, Ikeda W, Fujito T, Morimoto K, Takeuchi M, Monden M, Takai Y. Direct binding of 
cell polarity protein PAR-3 to cell-cell adhesion molecule nectin at neuroepithelial cells of 
developing mouse. J Biol Chem. 2003 Feb 21; 278(8):5497-500. 
Tanentzapf G, Tepass U. Interactions between the crumbs, lethal giant larvae and bazooka 
pathways in epithelial polarization. Nat Cell Biol. 2003 Jan; 5(1):46-52. 
Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signaling pathways: insights into insulin 
action. Nat Rev Mol Cell Biol. 2006 Feb; 7(2):85-96. 
Tavakkol A, Elder JT, Griffiths CE, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, 
Voorhees JJ. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and 
IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol. 1992 Sep; 99(3):343-9. 
Tserentsoodol N, Shin BC, Suzuki T, Takata K.Colocalization of tight junction proteins, occludin 
and ZO-1, and glucose transporter GLUT1 in cells of the blood-ocular barrier in the mouse eye. 
Histochem Cell Biol. 1998 Dec; 110(6):543-51. 
Ting SB, Caddy J, Hislop N, Wilanowski T, Auden A, Zhao LL, Ellis S, Kaur P, Uchida Y, 
Holleran WM, Elias PM, Cunningham JM, Jane SM. A homolog of Drosophila grainy head is 
essential for epidermal integrity in mice. Science. 2005 Apr 15; 308(5720):411-3. 
Tsuruta D, Green KJ, Getsios S, Jones JC. The barrier function of skin: how to keep a tight lid on 
water loss. Trends Cell Biol. 2002 Aug; 12(8):355-7. 
Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Günzel D, Fromm M, Kemler R, Krieg T, Niessen 
CM. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. 
EMBO J. 2005 Mar 23; 24(6):1146-56. 
Turksen K, Troy TC.Barriers built on claudins. J Cell Sci. 2004 May 15; 117(Pt 12):2435-47. 
Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, 
Kathuria S, Chen E, et al. Insulin-like growth factor I receptor primary structure: comparison with 
insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986 
Oct; 5(10):2503-12. 
Vasioukhin V, Bauer C, Yin M, Fuchs E. Directed actin polymerization is the driving force for 
epithelial cell-cell adhesion. Cell. 2000 Jan 21; 100(2):209-19. 
Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King 
GL, Kahn CR. The role of endothelial insulin signaling in the regulation of vascular tone and 
insulin resistance. J Clin Invest. 2003 May; 111(9):1373-80. 
                                                                                                                                  References 
 83
Vorbrodt AW, Dobrogowska DH. Molecular anatomy of intercellular junctions in brain 
endothelial and epithelial barriers: electron microscopist's view. Brain Res Brain Res Rev. 2003 
Jun; 42(3):221-42. 
Wallow IH, Engerman RL. Permeability and patency of retinal blood vessels in experimental 
diabetes. Invest Ophthalmol Vis Sci. 1977 May; 16(5):447-61. 
Wattel F, Mathieu D, Coget JM, Billard V. Hyperbaric oxygen therapy in chronic vascular wound 
management. Angiology 1990; 41:59–65. 
Williams CD, Rizzolo LJ.Remodeling of junctional complexes during the development of the 
outer blood-retinal barrier. Anat Rec. 1997 Nov; 249(3):380-8 
Wu H, Feng W, Chen J, Chan LN, Huang S, Zhang M. PDZ domains of Par-3 as potential 
phosphoinositide signaling integrators. Mol Cell. 2007 Dec 14; 28(5):886-98.7  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                  References 
 84
Acknowledgements  
Next to will of the God, this thesis is the outcome of the tremendous support and stimulation from 
my family, scientist colleagues and all other supportive fellows in the University of Cologne. I am 
exceedingly grateful to my adviser, Prof. Carien Niessen. She was the central organizer for the 
progress and troubleshooting in the course of my thesis work. Besides providing me a science 
project, Carien taught me big important lessons in science profesion as well as in personal life. I 
am also highly indebted to organizers of the international graduate school for genetics and 
functional genomics (IGS-GFG) for providing the funding and supportive environment in 
Germany. Thereby my deepest thanks go to Dr. Brigitte von Wilcken-Bergmann, Dr. Isabell Witt, 
Mrs. Kathy Joergens and Prof. Maria Leptin in IGS-GFG. 
 I would also thank members of my thesis committee, Prof. Dr. Jens C. Breuning, Mats Paulsson 
for their patience with my committee meeting, critical reading of my manuscript and their 
comments. 
My kind colleagues in the Niessen lab provided a very friendly and sociable atmosphere which 
facilitated my graduate career much easier outside my home land. Specially I wish to thank 
Mehmet Akyuez, Dr. Christian Michels and Christian Guenschmann who never hesitated to offer 
help in hard times. I would like to sincerely thank all present and former members of the lab, 
specially Dr. Karla Seifert, Dr. Jeanie Scott, Annika Schmitz and Dr.Barbara Boggetti for 
excellent support and resolving scientific problems. Nadine Niehoff always helped me thoroughly 
in handling cell culture experiments and TER evaluations. Drs. Thomas Wunderlich, Andre 
Kleinridders and Mr. Martin Pal in the institute for genetics (University of Cologne) helped in the 
designing and generation of the Par-3 construct. I appreciate the help and discussions that all other 
laboratory and campus colleagues provided to me during my graduate career. I wish to express my 
cordial thanks to the secretarial, cleaning and disposal personal of the CMMC and the animal 
facility of the pharmacology department.  
The countless guiltless embryos and mice that were generated during my work were key for our 
understanding of scientific questions and I regret their scarification for scientific purposes and ask 
for forgiveness from God.  
My best friends, Mr. Amir Tahmasebipour, Prof. Steven W. Barger and Prof. Sue Griffin 
(University of Arkansas for medical sciences) provided me invaluable success formulas in life and 
science and contributed chiefly to my science accomplishments. 
 
Finally my parents who brought me to this world of wonders and educated me in the direction of 
highly admired merits, as well as my brother Mesut and my sister Ilaha contributed morally and 
emotionally to my achievement in life and academics and I wish to thank them from the bottom of 
my heart. 
                                                                                                            Acknowledgements 
 85
8 Erklärung 
Ich versichere, dass ich die von mir vorgelegte Dissertation selbständig angefertigt, die benutzten 
Quellen und Hilfsmittel vollständig angegeben und die Stellen der Arbeit – einschließlich 
Tabellen, Karten und Abbildungen -, die anderen Werken im Wortlaut oder dass diese 
Dissertation noch keiner anderen Fakultät oder Universität zur Prüfung vorgelegen worden ist 
sowie, dass ich eine solche Veröffentlichung vor Abschluss des Promotionsverfahren nicht 
vornehmen werde. Die Bestimmungen dieser Promotionsordnung sind mir bekannt. Die von mir 
vorgelegte Dissertation ist von Prof. Dr. Jens C. Brüning betreut worden.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Köln, November       Saeed Yadranji Aghdam 
 
 
                                                                                                                                  Erklärung 
 86
Curriculum Vitae 
  
  
Name          Saeed Yadranji Aghdam 
Nationality  Iranian 
Date of birth  June 23, 1981 
Place of Birth  Tabriz, Iran. 
 
Education 
Sept 2006- Jan 2011  PhD fellowship, Institute for genetics, University of 
Cologne, Germany 
PI Prof. Carien Niessen 
 
Oct 2002- Feb 2006 M.Sc. degree in Developmental Biology, Tehran 
University, Iran 
The role of Lithium Chloride on rat microglial cell survival in vitro 
PI Dr. Bahman Zeinali 
 
Sept 1998- Feb 2002  B.Sc. degree in Animal Biology, Tabriz university, Iran 
 
Sep 1993- May 1998 Diploma in Natural sciences, Valfadjr high school 
Tabriz-Iran 
 
Publications: 
Michels C. Aghdam S. Y. Niessen C. M. Cadherin-Mediated Regulation of Tight Junctions in 
Stratifying Epithelia. Ann. N.Y. Acad. Sci. 1165: 163–168 (2009) 
 
Aghdam S. Y. Barger S. W. Glycogen Synthase Kinase-3 in Neurodegeneration and 
Neuroprotection: Lessons from Lithium. Curr. Alzh. Res. 4: 21-31 (2007) 
  
Pashmi M. Ghorashi S. A. Salehi A. R. Moini M. Javanmard A. Qanbari S. Aghdam S. Y. 
Polymorphism of Bovine Lymphocyte Antigen DRB3.2 Alleles in Iranian Native Sarabi 
Cows. Asian-Aust. J. Anim. Sci. 19 : 775-778 (2006) 
 
 
 
                                                                                                                       Curriculum Vitae 
